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While mortality rates have been decreasing over the last 40 years, cancer remains a leading cause 
of death in the United States. Over 1.7 million people were diagnosed with cancer in 2019, and 
there were more than 600,000 cancer deaths. Of the 15 million cancer survivors in the US, nearly 
3 million reside in rural areas and experience 3% higher cancer incidence and 10% higher cancer 
mortality compared to their nonrural counterparts. During 2006-2015, the annual age-adjusted 
mortality rates for all cancer sites combined decreased at a slower pace in rural areas versus nonrural 
areas (-1.0% vs -1.6% per year, respectively), widening the disparity in mortality rates. Although the 
reasons for these disparities are not fully known, rural cancer survivors tend to be older, have 
additional comorbidities and poorer general health, and have a higher prevalence of lifestyle risk 
factors, such as smoking and lack of physical activity, that complicate survival and may 
contribute to the higher mortality rate. Nonadherence to cancer treatment is associated with 
poorer cancer outcomes, including higher rates of cancer recurrence or treatment failure and 
decreased survival. Reports of mortality have been up to four times as likely in nonadherent 
compared with adherent survivors. A growing set of studies have begun to document that cancer 
treatment adherence is poorer among rural populations, which may also partially explain the 
higher mortality rate observed in rural areas. This dissertation is comprised of three studies: 1) a 
systematic review of the role of digital health in rural oncology; 2) a data analysis of hospital and 
billing claims data examining geographic differences in sociodemographic and clinical factors 
associated with radiation treatment nonadherence; and 3) a multilevel, theory-driven examination 
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While mortality rates have been decreasing over the last 40 years, cancer remains a leading cause 
of death in the United States.1 Over 1.7 million people were diagnosed with cancer in 2019, and 
there were more than 600,000 cancer deaths. Rural residents represent approximately 14% of the 
328M people living in the U.S., with the majority being white (76%) or people of color (13%). 
Compared with national averages, rural residents earn a lower income, have lower levels of 
educational attainment, experience a higher poverty rate, and have a higher unemployment rate.2 
Of the 15 million cancer survivors in the US, nearly 3 million reside in rural areas and 
experience 3% higher cancer incidence and 10% higher cancer mortality compared to their 
nonrural counterparts.3 During 2006-2015, the annual age-adjusted mortality rates for all cancer 
sites combined decreased at a slower pace in rural areas versus nonrural areas (-1.0% vs -1.6% per 
year, respectively), widening the disparity in mortality rates.4 Although the reasons for these 
disparities are not fully known, rural cancer survivors tend to be older, have additional 
comorbidities and poorer general health, and have a higher prevalence of lifestyle risk factors, 
such as smoking and lack of physical activity, that complicate survival and may contribute to the 
higher mortality rate.5–8 A growing set of studies have begun to document that cancer treatment 
adherence is poorer among rural populations, which may also partially explain the higher 
mortality rate observed in rural areas.9–16,37–44  
Nonadherence to cancer treatment is associated with poorer cancer outcomes, including higher 
rates of cancer recurrence or treatment failure and decreased survival.9–16 Reports of mortality 
have been up to four times as likely in nonadherent compared with adherent survivors. Treatment 
adherence can be defined as the degree to which a patient’s behavior corresponds to the agreed 
upon treatment plan. There are many ways treatment nonadherence has been operationalized in 
the literature, including: two or more missed treatment appointments;17 actual treatment cycle 
length exceeding planned treatment cycle length;18,19 ratio between received and planned 
radiation therapy doses;20 unwarranted treatment interruption greater than one week;21 and 
medication possession ratio.9,12 To enhance our understanding of treatment adherence, it is 
important to distinguish between treatment adherence versus medication adherence, and 
adherence versus compliance or concordance. While medication adherence is more concerned 
with patient-administered doses and can be measured by medication possession ratio or pill 
counts, treatment adherence considers healthcare provider-administered treatments and may 
involve a unique set of barriers. The term ‘treatment compliance’ has evolved over the past 
decade to be more patient-centered and acknowledge the importance of shared decision-making 
with the term ‘treatment adherence’. Despite this evolution, it is difficult for researchers to 
document that the patient was involved in the selection of the treatment course, especially in 
secondary analysis of hospital data, often resulting in these terms being used interchangeably. 
Treatment concordance is clearer cut however, with a direct comparison between a set of 
discipline-recognized treatment guidelines and the treatment received by the patient. While 
treatment concordance is focused on the type and sequence of treatments received, treatment 
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adherence focuses on the amount of treatment received during a specific treatment type and 
course. 
Potential Factors Related to Cancer Treatment Nonadherence among Rural Population 
There has been little attention to factors that might help explain why adherence is poorer among 
rural cancer survivors. To understand reasons for cancer treatment nonadherence, it is imperative 
to understand the complex interplay between sociodemographic, cultural, and systems factors 
experienced by individuals living in rural settings. Below, the literature on each of these are 
highlighted.  
Sociodemographic. Rural residents are more likely to have lower educational attainment, higher 
poverty rates and are more likely to report treatment-related financial hardship compared with 
their nonrural counterparts, all of which may affect treatment adherence.6,22 A number of studies 
have shown that lower health literacy is related to poor medication adherence.23 With regard to 
financial distress, prior studies have shown that the degree to which treatment has created a 
financial burden is associated with medication nonadherence.22,24,25 Specifically, investigators 
found that nearly half of participants reported experiencing some form of financial distress and 
did not adhere to recommended prescription medication because of cost. Rural populations also 
have a higher proportion of elderly residents, who are more likely to be diagnosed with cancer 
and are at greater risk for polypharmacy issues and medication treatment nonadherence.6,7,26  
Culture. Culture is defined as the customary beliefs, social norms, material traits and 
characteristic features of everyday existence shared by people in a place or time.27 Culture may 
contribute to health beliefs, health behaviors and care-seeking behaviors, with these behaviors 
and beliefs being reinforced through close family and social networks.28 Rural culture is grossly 
understudied as it relates to cancer treatment adherence, yet culture provides the context to rural 
health challenges and a lens to better understand rural health disparities. The few available US 
studies come from examinations of rural culture in Appalachia, which may differ from rural 
culture in the South, Deep South, and Midwest. Key characteristics reported are family cohesion, 
strong Christian beliefs, medical mistrust, self-reliance, and a commitment and dedication to 
work.29 The lack of literature on rural culture indicates a need for community-engaged mixed 
methodology to ensure an accurate representation of rural culture in the design of culturally-
sensitive interventions that capitalize on the strengths of rural culture. 
Access to Care. Healthcare access barriers also contribute to the observed geographic disparity 
cancer mortality rates. Rural areas have a lower county-level physician supply, and importantly, 
a lower density of specialists and radiation oncologists than nonrural areas.30 Only 3% of 
medical oncologists practice in rural areas.31 Rural residents have longer median travel times to 
treatment centers, oncology specialists, and academic centers; higher volume centers are 
associated with improved patient outcomes.30,32 Median travel times range from 51 minutes to 97 
minutes.33 Poverty creates substantial transportation barriers, making it a challenge for rural 
residents to afford gas or even a car. It has been estimated that over 1.6M rural households do not 
have cars, mostly concentrated in the South, Appalachia, and the Southwest.34 Rural residents 
have limited access to patient support services. Notably, only 2% of health social workers 
practice in rural areas, with specialized oncology social workers being virtually nonexistent.35 
Moreover, rural residents are less likely to have access to palliative care and hospice services.30 
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The substantial access barriers faced by rural populations in turn influence treatment adherence 
and cancer outcomes.  
Access to Technology. Digital health technologies can support patient, provider, and system-
level needs, which may serve to mitigate rural health disparities, including those related to 
access; however, a digital divide is also apparent. 26% of rural residents live in areas that lack 
the infrastructure for broadband coverage.36 Of the remaining 74% who live in areas with the 
infrastructure, only 63% subscribe to it. This could be due to cost, lack of interest, or internet 
speed, given that 30% of those who subscribe lack high speed service.37 Additionally, rural 
patients are less likely to contact their provider by email or online messaging. 38 However, 91% 
of rural residents own a cell phone of some type, so digital communication could still represent a 
viable communication strategy. 
Study Design for Understanding Cancer Treatment Nonadherence in Rural Populations 
Reducing nonadherence represents a tangible solution to improve cancer outcomes. While prior 
studies have shown that cancer treatment adherence is poorer among rural populations, there are 
methodological limitations to consider. In reviewing the literature, 16 manuscripts considered 
cancer treatment adherence in rural populations with minimal variation in study design.9–16,39–46 
Most studies (11/16) were conducted among breast cancer survivors. Only 3 studies involved 
qualitative methods (2 interview-based studies and 1 focus group-based study);39,42,43 the 
remaining 13 articles relied on quantitative data sources. Only 1 study involved a prospective 
survey, which was limited by sample size (N=31).47 The other 12 studies utilized secondary data 
sources largely consisting of healthcare claims data. There were no studies identified that 
employed mixed methodology, which would provide rich insight into factors contributing to 
nonadherence. Evidence of theory-driven approaches was even more limited, with only one 
manuscript describing a theoretical model or framework guiding the study development.9 
Theories that can inform our understanding of the factors contributing to poor adherence as well 
as guide intervention development are needed. 
THEORETICAL FOUNDATION  
The Theory Derivation process, the structured set of procedures in which a parent theory or 
model is used to guide the development of a new model or theory in conjunction with a 
comprehensive review of the current literature, was employed to understand how potential 
factors related to treatment nonadherence may fit together and influence outcomes in rural 
populations.48 Two parent theories were considered: the Information-Motivation-Behavioral 
Skills Theory (IMB) and the Chronic Care Model (CCM).49,50 
IMB Model. IMB posits that individuals will likely initiate and maintain patterns of a target 
behavior if they are well-informed about the  behavior, motivated to act on that behavior, and 
possess the behavioral skills required to act effectively in support of that behavior.51 Key model 
components include: 1) information that is directly relevant to the performance of the health 
behavior and can be easily enacted; 2) personal motivation (i.e., attitudes toward personal 
performance of the health behavior) and social motivation (i.e., social support for enactment of 
the health behaviors); and 3) behavioral skills, or an individual’s objective abilities and sense of 
self-efficacy concerning performance of the health behavior.49 IMB theory assumes that health-
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related information, motivation, and behavioral skills are fundamental determinants of 
performance of a health behavior, and that information and motivation are  independent 
contributors to the performance of the health behavior. That is, well-informed individuals are not 
necessarily motivated to engage in a particular health behavior, and that highly motivated 
individuals are not necessarily well-informed about the target behavior.49 Additionally, the 
effects of information and motivation are seen primarily as a result of the application of 
behavioral skills to the initiation and maintenance of health promotion behavior.49 While the 
IMB model was originally established to guide interventions focused on reducing HIV risk 
behaviors (e.g., condom use), it is viewed as a generalizable approach to understanding and 
promoting health behavior more broadly.49 For example, it has been successfully applied to 
smoking cessation interventions,52 interventions to increase physical activity,53 breast self-
examination interventions,54 and interventions to improve medication adherence.55 Although an 
individual level model and thus limited in application to individual behaviors, an important 
benefit is that IMB takes into account behavioral skills, a component missing from previous 
theoretical models aside from Bandura’s Social Cognitive Theory.56 
 
Chronic Care Model. Given that multilevel factors contribute to cancer treatment nonadherence, 
with unique aspects likely associated with the observed disparities between rural and nonrural 
populations, a multilevel theoretical basis is required in the design and implementation of 
research in this area. The Chronic Care Model (CCM) is a well-established and validated 
framework that positions chronic care in the context of community.50 The CCM was designed to 
help improve the quality of chronic care delivery and health outcomes. The model highlights the 
interdependent importance of self-management support, delivery system design, decision 
support, and clinical information systems to support patients and their care providers in having 
productive interactions and improved patient outcomes. A 2009 review summarized the literature 
relevant to the CCM as observation, intervention, and evaluation studies focused on 
organizational characteristics, quality improvement, and cost effectiveness to benefit patients 
with congestive heart failure, asthma, and diabetes.57 A benefit to this model is its flexibility acts 
more as a framework than a packaged intervention, allowing researchers to tailor CCM elements 
to individual organizations, yet it lacks patient-level factors that influence care delivery. 
Critique and Synthesis of the IMB and CCM Model. While both the IMB and the CCM have 
demonstrated utility in health promotion and quality improvement, neither fully capture the 
multilevel factors relevant to adherence in rural cancer survivors. Bringing the IMB and the 
CCM together as the Information-Motivation-Behavioral Skills theory - Chronic Care Model 
(IMB-CCM; Fig. 1) provides a novel framework from which to study and address treatment 
nonadherence in rural cancer survivors. The IMB-CCM identifies that receipt of information 
during the cancer journey is necessary but not sufficient to achieve positive behavioral and health 
outcomes like treatment adherence and survival. In addition, behavioral skills to promote self-
management through patient engagement, along with personal and social motivation shaped by 
rural culture, information access and information utilization, are critical determinants. Individual, 
community and health system-level factors interact to influence outcomes, with unique aspects 
likely associated with the observed disparities between rural and nonrural populations. The 
combined IMB-CCM provided the theoretical foundation for the design of the dissertation 
studies and interpretation of results. Specifically, the IMB-CCM was used to inform survey and 
interview development, allowing me to systematically generate data that more fully explain 
factors contributing to treatment nonadherence in rural oncology. Furthermore, survey data 
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allowed for assessing additional constructs hypothesized to be related to rural culture, 
encompassing each aspect of the IMB-CCM, which were then utilized to further explore 
potential factors related to treatment nonadherence through in-depth interviews with rural cancer 
survivors. 
 
Figure 1. Information-Motivation-Behavioral Skills Theory applied to the Chronic Care 
Model in rural cancer care 
 
RESEARCH AIMS  
 
The premise of the dissertation research is that multilevel factors contribute to the observed 
geographic differences in cancer treatment adherence and outcomes, including sociodemographic 
inequities, differences in information and motivational factors, and diminished access to 
healthcare, psychosocial services, and technological advances. Rural cultural factors serve as 
barriers and facilitators to treatment adherence and may be positively impacted by digitally 
mediated interventions. However, extant studies aimed at determining factors contributing to 
nonadherence among rural cancer survivors have not fully investigated the social, behavioral, 
and systems-level factors that might be contributing to nonadherence. The purpose of the 
dissertation research was to elucidate factors associated with rural cancer treatment 
nonadherence that are amenable to targeted, tailored approaches to improve rural oncology 
outcomes. These goals were accomplished by a rigorous mixed methods approach utilizing a 
systematic review of available literature, cancer registry and hospital billing claims data, 
population-based surveys, and semi-structured interviews.  
 
Aim 1. Systematically and critically examine existing literature to understand how digital 
technologies have been used to support rural oncology care. 
 
Hypothesis: Digital health strategies have been less extensively utilized in rural cancer 




Rationale: Digital technology has the potential to support treatment adherence, yet it is unclear 
the extent that it has been utilized in rural cancer populations. 
 
Aim 2. Determine sociodemographic and clinical factors associated with nonadherence among 
rural and nonrural cancer patients using healthcare claims data. We utilized cancer registry and 
hospital billing claims data to distinguish sociodemographic and clinical factors associated with 
first-line cancer treatment nonadherence based on federally defined geography classifications 
(USDA 2013 Rural-Urban Continuum Codes).  
 
Hypothesis: Geography plays a significant role in radiation treatment nonadherence, with higher 
nonadherence rates being observed among rural cancer patients. 
 
Rationale: Rural cancer patients experience a 10% higher mortality rate compared with their 
nonrural counterparts, with geographic differences in adherence as a possible contributor to this 
increased mortality rate. Radiation treatment is both time and resource intense, making 
adherence especially challenging. 
 
Aim 3. Delineate social and behavioral determinants of treatment nonadherence among rural 
cancer patients using a mixed method approach. We administered a quantitative survey with 
constructs guided by Information-Motivation-Behavioral Skills theory. We then conducted an in-
depth examination of factors salient to rural culture in oncology patients within an asset-based 
framework, informed by survey results, and considering the potential acceptability for digitally 
mediated interventions (e.g., text messaging, mobile apps, Voice Assistant technology).  
 
Hypothesis: Factors relevant to the IMB-CCM are associated with treatment nonadherence. 
 





CHAPTER 2: Paper One 
 




Rurality is associated with higher cancer incidence rates, mortality rates, and treatment 
nonadherence. Rural residents face significant challenges, including higher poverty rates, lower 
educational attainment, diminished access to health and psychosocial services, and are more 
likely to be elderly. Health technologies may serve to address some of these disparities, yet a 
digital divide is also apparent in rural residents. 
Purpose 
To systematically and critically examine existing literature to understand how digital 
technologies have been used to support rural oncology care. We hypothesized that digital health 
strategies have been less extensively utilized in rural cancer populations compared with the 
general cancer population and other chronic diseases. 
Methods 
PubMed, CINAHL Complete, PsycINFO and Embase were searched using a combination of 
Medical Subject Headings terms and keywords. Studies were eligible for inclusion if they 
presented empirical data aimed at investigating the use of technology in rural oncology survivors 
and published in English in a peer-reviewed journal within the last decade. The Mixed Methods 
Appraisal Tool was used to assess methodological quality. 
Results 
Of the 515 unique articles identified, 69 articles were eligible for full-text screening, and 53 
articles met study inclusion criteria. Studies were classified into 4 categories Telemedicine (n= 
31), telephone (n= 11), internet (n= 9), and mobile phone (n= 3). Of the 53 articles, 12 were 
RCTs, 17 were quasi-experimental, 3 were descriptive, 11 were mixed methods and 10 were 
qualitative. Most of the studies involved patients only (n=30), did not provide a definition of 
‘rural’ (n=37), and were not specific to a cancer type (n=41). An in-depth examination of each 
study and its quality are presented and discussed. 
Conclusions 
While there are literature gaps regarding other technologies, further implementation and 
expansion of telemedicine and phone-based strategies in rural cancer care delivery is warranted. 
Overall, there is considerable room for growth in digital health for rural oncology. Social and 
behavioral determinants of health and access to technology must be considered. Future studies 





Cancer remains a leading cause of death in the United States, despite decreasing mortality rates, 
accounting for more than 600,000 deaths in 2019.1 Of the 15 million cancer survivors in the US, 
nearly 3 million reside in rural areas and experience 10% higher cancer mortality compared to 
their nonrural counterparts.3 During 2006-2015, the annual age-adjusted death rates for all cancer 
sites combined decreased at a slower pace in rural areas versus nonrural areas, widening the 
disparity in mortality rates.4 Rural cancer survivors tend to be older, have additional 
comorbidities and poorer general health, and as a group have a higher prevalence of lifestyle risk 
factors that complicate survival, such smoking, lack of physical activity and obesity.5–8 
Access to care is a major factor driving geographic disparities. Rural areas have a lower county-
level physician supply, and importantly, a lower density of specialists like radiation 
oncologists.30 Less than 3% of medical oncologists practice in rural areas.31 Rural residency has 
been associated with higher unmet care needs and reduced access to supportive care services 
among cancer survivors, including social work, palliative care, and hospice services.30,34,58 
Access to care issues are further exacerbated by the increased rate of rural hospital closures in 
recent years.59 Limited local health services means patients must travel further for care, with 
median travel times ranging from 51 minutes to 97 minutes.33 Additionally, poverty creates 
substantial transportation barriers, making it a challenge for rural residents who are also poor to 
afford gas or even a car. Since over 1.6M rural households do not have cars, transportation to 
treatment appointments presents a very real challenge.34 Web-based needs assessments have 
facilitated exploration of unmet rural cancer survivor needs, captured enduring survivorship 
issues and recommended the use of technology to better inform and support patients and connect 
providers.60,61 Digital health can support patient, provider, and system-level needs for distance-
based care strategies, which may serve to ultimately mitigate rural disparities in cancer outcomes 
that arise due to lack of access to care. 
Digital health 
Digital health can be defined as “using digital information, data, and communication 
technologies to collect, share, and analyze health information for purposes of improving patient 
health and health care delivery.”62 Telemedicine, which employs technology to administer 
distance-based healthcare, is one of the more widely used subcategories of digital health, while 
mobile applications (apps) are increasingly used for real-time or regular symptom assessments, 
health-related reminders, and tailored health feedback with studies reporting significantly 
improved health outcomes.63,64 While digital health technologies have potential to optimize 
health care delivery, key barriers impede broad implementation and the rate of healthcare 
digitalization and consumer demand has exceeded the healthcare systems’ ability to modernize 
its infrastructures and adapt to new workflows.65  Across all disease types and patient 
populations, there is a need to address these barriers to catch up with the technological curve and 
implement tools and strategies that are evidence-based. 
Digital health in chronic disease management 
Previous articles have reviewed the use of digital health technology in the management of a 
variety of chronic diseases, including hypertension, diabetes mellitus, rheumatology, chronic 
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obstructive pulmonary disease, inflammatory bowel disease, and mental illness.66–71 A 2015 
scoping review of information and communication technology (ICT) chronic disease 
interventions identified 350 studies targeting diabetes mellitus (n=103), cardiovascular disease 
(n=89), chronic respiratory disease (n=73), cancer (n=67), and stroke (n=18).72 With respect to 
cancer, this scoping review found that use of ICT interventions were most broadly applied in 
cancer care compared with other chronic diseases, with a wider variety of activities involving 
self-management and engagement in their healthcare. Studies were more likely to include ICT 
interventions for one-way delivery of educational materials versus a patient-centered exchange 
of information and shared decision-making. Additional articles have reviewed availability and 
features of mobile applications related to cancer across the care continuum.73,74 Specific to the 
cancer treatment phase, Davis categorized apps by the following use cases: supporting patient-
provider communication, patient information management, and managing treatment side 
effects.74 Digital health strategies have also been examined within subpopulations, including 
adolescent, young adult and geriatric cancer survivors, but have yet to be examined within the 
rural context.75,76 
Digital health in rural healthcare delivery 
A 2019 study found that those living in rural areas had reduced odds of having internet access 
compared with those residing in nonrural areas (OR 0.75; 95% CI 0.67-0.84).77 In this paper we 
will refer to the rural digital divide as the inability of rural populations to access services and 
information through technology. A key contributor to the rural digital divide and critical to the 
deployment of digital health strategies is access to the mobile, internet or broadband 
infrastructure that supports these tools. Access could occur through a fixed connection at home 
or work, or through cellular service on a mobile phone. The Federal Communications 
Commission’s 2019 Broadband Deployment Report found that over 26% of Americans in rural 
areas lack coverage from fixed terrestrial 25 Mbps/3 Mbps broadband that would allow for home 
internet access, as compared to only 1.7% of Americans in nonrural areas.36 Deployment of 
mobile Long-term Evolution, more commonly known as LTE  and the pathway to achieve high 
speed cellular internet service, still lags in rural areas. Specifically, only 70% of the rural 
population has service with a median speed of 10 Mbps/3 Mbps versus 93% of the nonrural 
population. An important step in addressing these disparities is to develop more granular 
broadband availability maps, a step taken by Congress in March 2020 in passing the Broadband 
Deployment Accuracy and Technological Availability Act.37  
Social drivers relevant to technology access and use include higher poverty rates, lower 
educational attainment, and a higher proportion of elderly residents in rural 
communities.6,9,12,40,78 The Pew Research Center reported that 63% of rural residents say they 
have a broadband internet connection at home, compared with 75% of nonrural residents.79 
Similarly, 71% of rural residents reported having a smartphone, versus 83% of nonrural 
residents. Additionally, 15% of rural adults say they never go online, compared with 9% of those 
who live in nonrural communities. Specific to use as a health resource, rural residents are less 
likely to manage personal health information online or email a healthcare provider.38 Technology 
tools such as mobile apps are being used in the general cancer survivor population,73 yet the 





Digital health strategies may be used to mitigate rural cancer disparities. Despite progress made 
in understanding how digital health can enhance cancer care, previous reviews have not focused 
on their use in rural populations. The aim of this study was to systematically and critically 
examine existing literature to understand how digital technologies have been used to support 
rural oncology care. We hypothesized that digital health strategies have been less extensively 
utilized in rural cancer populations compared with the general cancer population and other 
chronic diseases. 
METHODS 
We conducted a systematic literature review of technology use in rural oncology research 
studies. Studies were eligible for inclusion if they presented empirical data from a human 
subjects study aimed at investigating the use of technology in rural cancer care delivery and 
published within the last decade (January 2009 – December 2019). Articles were excluded if 
they did not involve cancer survivors (defined from diagnosis forward), did not include rural 
participants, or were not available in English in a peer-reviewed journal. Searches were 
performed in PubMed, CINAHL Complete, PsycINFO and Embase to identify relevant articles 
using a combination of Medical Subject Headings terms and keywords determined based on the 
literature (Paper 1 Appendix 1).  
Data collection 
We first reviewed titles and abstracts of search results. Full text of likely eligible articles was 
retrieved, screened by one research team member, and then verified by a second. Disagreements 
between authors were resolved by discussion or consultation with a third author. Reasons for the 
exclusion of full text articles were recorded. Data was extracted onto a standardized data 
abstraction sheet by the first and second authors independently. Discrepancies were discussed 
and resolved by the study team. The following information was extracted: publication year, first 
author, country, study design, study population, rural definition (if provided), rural sample size, 
total sample size, cancer site(s), type of technology considered and study outcome(s). 
Technology type was categorized as telemedicine (video phone visits and telemonitoring 
systems), telephone, mobile phone (text messages and phone-based apps), and internet (websites 
and web-based applications). These categories were selected to compare use of digital health in 
the rural cancer context with general cancer and other chronic disease populations presented by 
Wildevuur et al.72 
Quality appraisal 
Each study that met inclusion criteria were assessed for study quality using the Mixed Methods 
Appraisal Tool (MMAT), which allows for the critical appraisal of quantitative, qualitative, and 
mixed methods studies.80,81 The MMAT was developed to address the challenges of critical 
appraisal in systematic reviews involving more than one study design. Each study type is 
assessed by five quality indicators, items that were developed from the literature as well as 





The initial search yielded 595 articles. An additional 5 articles were identified through review of 
reference lists. After removing duplicates, there were 515 unique articles remaining. Review of 
titles and abstracts resulted in 69 articles eligible for full-text screening, and 53 of these articles 
met study inclusion criteria (Figure 1). 
Study Quality 
Of the 53 articles that met inclusion criteria, only 22 provided sufficient information to assess 
study quality using a standardized tool (Figure 2). Information was most complete for qualitative 
studies. Eight out of 10 qualitative studies provided complete MMAT assessment information, 
while 5 out of 12 randomized controlled trials, 3 out of 17 quasi-experimental studies, 2 out of 3 
descriptive studies, and 4 out of 11 mixed methods studies provided complete MMAT 
assessment information. Five qualitative studies and 1 mixed methods study performed the best 
in quality reporting per the MMAT, meaning that reporting was sufficient to assess all five of the 
MMAT quality criteria for the respective study type (Figure 3). Quantitative non-randomized 
studies were the lowest performing. 
Methodological Characteristics 
Of the 53 articles, 12 were randomized controlled trials (RCTs), 17 were quasi-experimental, 3 
were descriptive, 11 were mixed methods and 10 were qualitative. Most of the studies involved 
patients only (n=30), did not provide an explicit definition of ‘rural’ (n=37), and were not 
specific to a cancer type (n=41) (Table 1). Of the 12 RCTs, the median sample size was 142 
(mean=181.91 [45-451]). Technology utilized in the 53 articles were categorized as 
Telemedicine (n= 31), telephone (n= 11), internet (n= 9), and mobile phone (n= 2). Table 2 
quantitatively compares the categorical findings of this study with the digital technology review 
by Wildevuur and colleagues across five chronic diseases.72 Telemedicine makes up a much 
larger percentage of studies for rural cancer survivors versus the general cancer population, while 
internet and mobile strategies were less commonly used.  
Types of Technology 
Telemedicine. Telemedicine articles focused on care delivery (n=22), training (n=4), 
multidisciplinary cancer teleconferences (i.e., tumor boards, n = 2), telemonitoring (n=2), and 
cancer support (n=1). The most thoroughly described rural teleoncology model is the Townsville 
Cancer Centre (TCC) teleoncology program established in 2007 for rural cancer care delivery, 
totaling 974 participants.84 Medical oncologists at TCC provide their services via 
videoconference with rural-based doctors, chemotherapy-competent nurses, allied health workers 
and patients in consultation. Initially patients were required to attend at least one face-to-face 
appointment at TCC, which became optional in 2009. The program was expanded to radiation 
oncology in 2011.85 The studies conducted were able to establish that teleoncology was feasible, 
acceptable to patients and healthcare workers, and cost-effective.86–90 High patient satisfaction 
was reported with the quality of the video consultation and in establishing rapport with the 
specialist over video conference. Patients overall preferred video conference to face-to-face 
consultations and were very satisfied with care received via the teleoncology program.85,87,91 
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Healthcare professionals similarly reported high satisfaction in the program, including patient 
convenience, interprofessional communication, expanded scope of practice, and continuity of 
care and maintenance of patient safety.90 Thaker determined that the TCC model resulted in a net 
savings of $320,118 over 56 months and that costs would have to increase by 72% to negate the 
savings.88 Two additional telemedicine studies examined use of mobile chemotherapy units in 
rural areas of the United Kingdom.92,93 Specialty care delivery examined via the use of 
telemedicine in rural areas included speech pathology services for head and neck cancer patients, 
pharmacy services, mental healthcare, pain management, genetic counseling, and palliative 
care.94–103 These studies were in agreement that telehealth is less expensive, equal quality, more 
efficient, and had high satisfaction for delivering rural oncology care. 
Telemedicine as a training platform was examined in the rural cancer setting in four studies and 
was a feasible and satisfactory means of delivering real-time, interactive training to providers 
who might not otherwise have access to such programs. Training included continuing medical 
education, training on a cancer support intervention, and surgical oncology telementoring.99,104–
106 Connecting community oncologists with multidisciplinary cancer conferences (tumor boards) 
via teleconference was considered in two articles.107,108 These articles demonstrated initial 
feasibility of providing oncologists in rural areas and at smaller institutions access to tumor 
boards to improve the quality and continuity of care.  
Feasibility of telemonitoring for rural cancer patients was considered in two articles, with the 
first determining that the potential exists for melanoma follow-up telemonitoring if the 
technology is tailored by age, skill level, area of residence and time since diagnosis.109 Petitte 
and colleagues remotely collected physiologic data in lung cancer patients who were post-
hospital discharge.110 Despite low sample size, telemonitored data transmission was feasible in 
rural areas with high satisfaction. Lastly, one study considered the acceptability of telehealth 
support group services for rural American Indian and Alaskan Native communities and found 
that participants valued the opportunity to connect with other similar survivors living in remote 
areas.111 
Telephone. Telephone studies (n= 11) were composed of group or individual phone calls. 
Studies focused on weight loss (n=4), palliative care (n=2), caregiver support (n=3), and decision 
support (n=2). A quasi-experimental study by Befort utilized weekly group phone sessions in 
addition to a specified reduced calorie diet and physical activity plan.112 The intervention 
resulted in significantly improved clinical outcomes and quality of life. This study demonstrated 
feasibility and favorable outcomes in a group of rural breast cancer survivors, though the benefits 
could not be directly attributed to the technology portion of the intervention. The second phase of 
the study involved a 12-month intervention in which participants were randomized to either 
continued biweekly phone-based group counseling or mailed newsletters.113 The study concluded 
that the technology intervention improved the magnitude of weight loss maintained over 18 
months as well as increased the proportion of participants who maintained clinically significant 
weight loss. Additionally, Fazzino reported that this intervention was successful in improving 
physical activity outcomes over 18 months, as measured by accelerometer.114 A follow-up 
qualitative study revealed technology-related themes of the group phone counseling sessions 
providing benefits of accountability and connectedness, as well as the inconvenience of 
scheduling and duration of the sessions (1 hour).115 
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Rural residents are less likely to have access to palliative care and hospice services.30 The 
ENABLE II randomized controlled trial, based on its predecessor, Project ENABLE, was 
designed to facilitate early integration of palliative care.116 Rural patients with advanced cancer 
were randomly assigned to a phone-based, nurse-led educational and care coordination palliative 
care intervention or to receive usual care. Patients receiving the technology intervention were 
found to have significantly higher self-reported quality of life and mood, while comparisons of 
symptom intensity and days in the hospital, ICU and emergency department visits were not 
significantly different.116 When the intervention was applied using a waitlist control, patients 
receiving the technology intervention upon enrollment versus 3 months later had higher 1-year 
survival rates.117 The ENABLE intervention was extended to caregivers in the ENABLE III 
randomized controlled trial, which was found to lower depression scores among caregivers.118 
The ENABLE research team conducted a qualitative study to support further scalability of the 
intervention in rural settings and found that caregivers perceived intervention delivery via 
telephone to be acceptable, while there was concern that internet-based technologies may have 
limited use due to lower skill and access.119 
Providing treatment decision support within the constraints of a fast-paced clinic environment 
has led to remote delivery of consultation planning. One method involves coaching patients to 
develop a list of personalized questions to bring to their next clinic appointment to promote 
patient involvement in their care and treatment decisions. Two studies included in this review 
examined treatment decision support. These studies found that remote consultation planning was 
equally effective, with comparable quality, cost and value as in-person consultation planning, 
while increasing accessibility of decision support services in rural communities.120,121 
Internet. Studies utilizing websites (n=9) included in this review examined educational, 
symptom management, and lifestyle support programs delivered in an online format to address 
access issues in the rural setting. In one such example, the Oncology Associated Symptoms and 
Individualized Strategies (OASIS) program was developed to provide tailored cancer symptom 
self-management support delivered through an online format to address access to care issues in 
rural cancer populations.122 The team used a three-phase mixed methods design engaging rural 
stakeholders to develop the program and assess usability. One of the qualitative themes that 
emerged regarded technology access and highlighted that while not all patients used technology, 
they often had family members and caregivers who did. This OASIS research program is still in 
progress, with results on feasibility and acceptability of the intervention incorporating nurse-
coach contact forthcoming. 
Syrjala described a personalized, Internet-based survivorship care program targeting emotional 
distress, depression, and fatigue for hematopoietic cell transplant survivors.123 Survivors more 
likely to engage with the online site were female, had active graft-vs-host disease as a side effect 
to their cancer treatment, and had moderately elevated levels of cancer distress. Importantly, 
engagement was strong in subgroups with less access to care, including rural survivors, although 
eligibility criteria excluded those without computer or email access. 
Fennell presented a website with community involvement to address psychosocial information 
needs that are relevant, accessible and acceptable to increase rates of support service use among 
rural cancer survivors.124 Importantly, website design not only incorporated information targeted 
to rural populations but also sought to address attitudinal barriers to service use (e.g. medical 
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mistrust, belief that help is unnecessary or shows weakness, finding help is too hard) and tailored 
information by stage of change and level of distress. Survey results documented that participants 
were significantly more willing to access professional and peer support after using the website, 
and that 67% of respondents were more motivated and confident in accessing resources. 73% of 
respondents also felt less isolated after utilizing the website. 
One qualitative study used semi-structured interviews to examine the use of an online lifestyle 
intervention and found that the program motivated participants to increase their walking and 
improved self-reported physical and quality of life outcomes.125 Key benefits of the program 
discussed by participants included individualized step goals, the website’s ease of use, and the 
program contributing to the participant’s self-awareness and engagement in their health. 
Participants would have preferred the program to be more interactive, with the ability to make 
comments on their activity and engage online with study staff. Methodological limitations of this 
study were the low sample size (N=9) and eligibility excluding those without access to the 
internet. 
Support groups have been shown to improve psychosocial symptoms associated with cancer and 
improve quality of life, yet access is an issue for rural residents.126,127 CancerChatCanada offered 
professional-led live-chat support groups for cancer patients and caregivers that were held 
weekly for 90 minutes over the course of 10-12 weeks. The program led 55 of these online 
support groups, enrolling 351 participants with more than half from rural areas. Of the 55 groups, 
19 were for breast cancer survivors and 19 were for caregivers. Weekly attendance in the group 
sessions averaged 75% with a 26% dropout rate. Participants reported high satisfaction and 
psychosocial benefit, with any initial discomfort in communicating online in a live chat group 
being outweighed by access to support at home. Typing versus talking was viewed as a benefit 
by giving added time for reflection, organizing thoughts and not impending emotional expression 
(e.g. able to cry while typing but not while talking). 
Koczwara described an online education program incorporating palliative and supportive care, as 
well as strategies to support multidisciplinary care in the rural setting.128 Content was developed 
by utilizing stakeholder surveys and focus groups. Use of the online format allowed for a broader 
reach than in-person instruction, and program evaluation indicated high satisfaction.  
Mobile phone. Only 2 studies focused on using a mobile app among rural cancer survivors. The 
first study used a mixed methods approach and developed a health services locator app for both 
providers and cancer survivors; however, additional studies are needed to evaluate the feasibility, 
acceptability and effectiveness of implementing this app on a broader scale.129 Secondly, 
Baseman and colleagues developed a breast cancer survivorship care app called 
SmartSurvivor.130 Components of the app included a medical profile, a journal section with a 
tracking tool for self-monitoring, calendar links for reminders and appointments, tailored 
survivor tips and tools, and the ability to audiorecord for documenting notes and appointment 
questions. Qualitative results highlighted key features and utility of the app, while also 
discussing the need for it to be tailored for rural users. Overall, the app was found to be both 
feasible and acceptable as a breast cancer survivorship tool and could serve as a foundation for 





While there have been other reviews focused on digital technology use in cancer care delivery, 
this is the first within the rural cancer setting.73–76,131 The overall aim of this study was to 
systematically and critically examine existing literature to understand how digital technologies 
have been used to support rural oncology care. Rurality is associated with higher cancer 
incidence and mortality rates, and rural residents face significant challenges influencing access to 
healthcare. Health technologies may serve to address some of these disparities, yet we correctly 
hypothesized that digital health strategies have been less extensively utilized in rural cancer 
populations compared with the general cancer population and other chronic diseases.  
We identified 53 studies that addressed the use of technology in rural cancer care delivery, a 
comparatively small number, representing a significant gap in the literature. The limited number 
of studies is surprising since digital health strategies could improve access to care issues faced by 
rural cancer survivors; however, mobile and broadband availability remains an issue in rural 
areas.36,79 Across all studies was the consensus that rural cancer survivors value digital 
technology approaches to their care, with results varying by type of technology.  
A notable finding from the present review was that most studies used telemedicine approaches. 
While the designs and approaches differed across these studies, it was generally concluded that 
telemedicine is a feasible and acceptable approach to improving care delivery. Telemedicine 
studies were able to demonstrate both improved patient outcomes and improved access to care. 
Specifically, a randomized controlled trial examining telecare management on pain and 
depression outcomes among rural and nonrural cancer patients found a significant increase of 60 
depression free days, as well as an increase in quality-adjusted life years compared to the usual 
care group.98 A palliative care telemedicine study found significantly improved anxiety and 
appetite at the first follow-up visit among rural cancer patients.102 Implementing a 
comprehensive program of telemedicine and patient navigation, genetic counseling increased for 
ovarian cancer patients increased from 37% to 96% and for triple negative breast cancer patients 
from 69% to 91%. Genetic testing doubled for ovarian cancer patients and increased from 59% 
to 86% in triple negative breast cancer patients.101  These studies speak to the potential utility of 
telemedicine approaches to address cancer survivorship in rural settings.  
Due to limited access to oncology specialists, including palliative care, rural cancer patients rely 
on their local medical providers to manage their illness, yet there is a need to support cancer 
management education for these providers.128,132,133 While only four studies that examined 
telemedicine as a training platform and telementoring met study inclusion criteria, widespread 
success of telementoring models exist in other areas of medicine.8 For instance, Project ECHO 
(University of New Mexico [UNM] Health Sciences Center, Albuquerque, NM) is a 
telementoring platform for implementing best practices at scale by employing interdisciplinary 
teams of experts to mentor multiple rural providers participating remotely from their practices 
using videoconferencing technology.134 The Cancer ECHO Initiative has 75 cancer ECHO hubs 
worldwide (39 in the United States) offering 135 programs in 14 countries. Project ECHO was 
originally initiated to improve hepatitis C care delivery in 2003 and has since been expanded to 
393 hubs with 850 programs in 39 countries that cover training for community providers on 
more than 70 conditions, including cancer. The findings herein support continued expansion of 
telemedicine and telementoring approaches to address rural cancer care delivery. 
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While telemedicine represented the largest category of studies in the present review, phone-
based studies had the most RCTs for both quantity and percentage (7/11, 64%). Phone-based 
interventions supported weight loss in cancer survivors and improved patient outcomes in 
palliative care. Phone-based strategies increased survivors’ feelings of connectedness and 
facilitated access to care, and, as noted by the ENABLE team, was preferred over internet-based 
technologies that may have limited use due to lower skill and access.119 Future studies should 
focus on implementation strategies to optimize these programs for long-term sustainability. 
Internet-based digital health approaches involving patients may emerge as being useful but may 
also pose a potential challenge for implementation in rural populations. Rural residents are less 
likely to have regular access to the internet, manage personal health information online or email 
a healthcare provider.38 Participants have reported concern with using internet-based 
interventions for palliative care due to lower comfort with technology and access to the 
internet.119 Patients may be more likely to attend in-person counseling, attributed to a significant 
association found between decreased computer comfort and attendance rate in telegenetics.100 
Other telemedicine studies did not support this finding, but the discord may be attributed to the 
skills and technology needed to virtually attend a genetic counseling appointment from home 
versus teleconference with a oncology specialist from a cancer clinic or primary care facility 
closer to home.  
Ease of use and technological requirements are important considerations in rural populations. For 
instance, applications or ‘apps’ can be desktop, mobile, and/or internet-based. Desktop apps 
usually have all the features of a program, whereas the mobile equivalent is a simpler and easier-
to-use version. Internet or web apps can have extensive features too, but they must leverage the 
capabilities of the internet connection and the web browser program. Only 2 studies involved a 
mobile app, yet the more streamlined format may be preferred over web-based versions in rural 
populations. To this point, a prior secondary analysis of the National Cancer Institute’s Health 
Information National Trends Survey found that rurality was associated with the use of mHealth 
applications for making treatment, indicating mobile phone apps as a means to increase access to 
health information.135 There is a need to further expand this area of research.  
The majority of studies (37/53) did not provide a definition of ‘rural’. There are a number of 
ways that geography can be classified for the purposes of rural research and policy. Each 
classification has its own unique attributes and implications, further complicating comparison 
across studies even when the classification is reported (see Paper 1 Appendix 2). In the US, the 
main classifications are provided by the US Census Bureau, the US Office of Management and 
Budget (OMB), and the US Department of Agriculture (USDA). The USDA utilizes two 
classifications, the Rural-Urban Commuting Area (RUCA) codes and the Rural-Urban 
Continuum Codes (RUCC).136,137 Australia, from which a number of the telemedicine studies 
presented in this review were published, uses the Accessibility/Remoteness Index of Australia 
(ARIA). Similarities do exist between the 4 US-based classifications; namely, the same 
definition of urban area (UA) and urban cluster (UC), incorporating UAs as a key attribute, and 
basing population sizes on 2010 Census data. The US Census Bureau defines its categories as 
“Urban Area”, “Urban Cluster”, and “Rural Area” by population size and density in census 
areas.138 A limitation of this method is apparent for single census tracts that are composed of 
both urban and non-urban census block groups or census blocks. OMB defines its categories by 
population size in counties, first defining Metropolitan and Non-Metropolitan, then further 
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subdividing Non-Metropolitan into Micropolitan and Non-core).139 This classification system has 
the similar limitation of the Census Bureau definition, with larger counties having the potential 
to include both urban and rural areas and being more likely to underestimate the rural population. 
USDA RUCA codes range from 1 to 10 based on population density, proximity to an UA, and 
daily commuting patterns. While it has the benefit of including the functional relationship of 
commuting rates, it fails to account for distance to services and sparse populations in large 
census tracts. RUCC is also provided by the USDA, but is based on population size, proximity to 
an UA, and adjacency to a metro area. In this respect it is more similar to OMB but minimizes 
the effects of county size variations by defining geographic units of finer granularity. Aside from 
the broad implication of complicating comparisons across studies, the definition chosen can 
result in different areas being classified or not classified as rural, such that estimates of the rural 
US population range from 15 - 19.3% and estimates of rural land ranging from 72 - 95%.  
As evident by the present review and assessed by the MMAT, there are limitations to the state of 
the science. Despite the availability of standardized reporting guidelines by study design like 
CONSORT and STROBE, there is room for improvement in practice in terms of both study 
design and reporting results.  Overall, there were few randomized trials and samples sizes low. 
Most studies restricted participants to those with internet access without reporting on how many 
potential participants were excluded due to access. Few studies measured access to care 
variables. No studies examined the use of interactive voice response, electronic health records, 
patient portals, or social media in the context of rural cancer survivors. Despite the benefits of 
text messaging as an intervention strategy, including reach, engagement, low cost, and 
documented effectiveness in directly supporting behavior change, no studies using text 
messaging were identified for inclusion in this study.140 Given the study limitations and 
knowledge gaps identified in this review, we recommend the following: Investigators should 
take advantage of available guidelines like CONSORT at both the study design and reporting 
phase to improve the quality of literature in this research area. Furthermore, studies should 
continue to build upon and expand telemedicine and phone-based interventions as digital health 
strategies at a more widespread scale, yet also consider innovative or underutilized strategies like 
interactive voice response and text messaging. 
This review is not without some limitations. We could not measure quality in every study and 
were restricted to evaluating the information reported. Broad variation in study design prevented 
us from performing meta-analyses. Varying definitions of rurality presented by the US Census 
Bureau (urban vs not urban), the US Office of Management and Budget (metropolitan vs non-
metropolitan), the US Department of Agriculture (Rural-Urban Commuting Area Codes and 
Rural-Urban Continuum Codes), Australia (Accessibility/Remoteness Index of Australia), and 
research teams (patient travel distance), and thus adopted inconsistently in the literature led to 
difficulty in generating comparisons across studies. As is the case with other systematic reviews, 
there may be publication bias present, with studies finding null results being less likely to be 
published and therefore included in this review. Despite the limitations, our study synthesizes 
lessons learned thus far on designing and implementing digital health studies among rural cancer 
survivors and highlights the gap in knowledge on technology use in this population. 
To conclude, unique challenges faced by rural cancer survivors require targeted approaches. 
More research is needed involving studies of high scientific and methodological rigor and 
employing cutting-edge technology to support this underserved population. Critical to reducing 
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the rural digital divide and the deployment of digital health strategies is increasing mobile, 
internet or broadband service in rural areas. While steps are being taken to address this 
geographic disparity, the fact remains that nearly 30% of Americans live in areas that lack the 
coverage needed for home internet. The findings of this review suggest further implementation 
and expansion of telemedicine and phone-based strategies in rural cancer care delivery. Ease of 
use and technological requirements are important considerations in rural populations. Future 
rural cancer control studies would benefit from the use of mixed methodology and a theoretical 
framework to guide study development. There are significant gaps in the literature regarding 
patient portals, mobile apps, interactive voice response, social media, and text messaging that 
should be investigated. Opportunities exist for innovative digital health technologies to address 




Table 1. List of studies included in systematic review 
Study Year 
First 












A comprehensive program enabling effective delivery of 
regional genetic counseling 2018 Brown, J US Quasi 
Distance from 
clinic Patients -- -- 118 Multiple 
Utilization of genetic 
counseling (in-person and 
telemedicine) 
A pilot trial of a speech pathology telehealth service for 
head and neck cancer patients 2012 Burns, CL Australia Quasi Not defined Multiple 20 0 20 
Head and 
neck Program evaluation 
A tele-oncology model replacing face-to-face specialist 
cancer care: perspectives of patients in North Queensland 2014 Sabesan, S Australia Qual Not defined Patients 35 0 35 Multiple 
Exploratory, thematic 
analysis of interviews 
Acceptability and feasibility of an e-mental health 
intervention for parents of childhood cancer survivors: 
"Cascade" 2016 
Wakefield, 
CE Australia RCT ARIA Caregivers 9 36 45 Multiple Feasibility, acceptability 
Assessing the feasibility of a virtual tumor board program: 
a case study 2014 Shea, CM US Mixed Not defined 
Healthcare 
providers 12 16 28 Multiple 
Acceptability, barriers, 
value 
Can we use technology to encourage self-monitoring by 
people treated for melanoma? A qualitative exploration of 
the perceptions of potential recipients 2014 Hall, S Scotland Qual Not defined Patients 14 5 19 Melanoma 
Thematic analysis of 
interviews 
Cost effectiveness of telecare management for pain and 
depression in patients with cancer: results from a 
randomized trial 2014 
Choi Yoo, 




Cost savings from a telemedicine model of care in 
northern Queensland, Australia 2013 Thaker, DA Australia Quasi Not defined Patients 147 0 147 Multiple Cost-savings 
Development of a virtual multidisciplinary lung cancer 
tumor board in a community setting 2013 
Stevenson, 
MM US Quasi Not defined 
Healthcare 
providers 10 0 10 Lung 
Acceptability, barriers, 
value 
Do teleoncology models of care enable safe delivery of 
chemotherapy in rural towns? 2015 Chan, BA Australia Quasi Not defined Patients 89 117 206 Multiple 
Dose intensity, toxicity 
rates 
Enhancing access to cancer education for rural healthcare 
providers via telehealth 2011 
Doorenbos, 
AZ US Quasi Not defined 
Healthcare 
providers 71 0 71 Multiple Program evaluation 
Enhancing Chemotherapy Capabilities in Rural Hospitals: 
Implementation of a Telechemotherapy Model (QReCS) 
in North Queensland, Australia 2018 Sabesan, S Australia Quasi Not defined Patients 62 0 62 Multiple 
Enablers, barriers, 
provision, Rates of 
treatment delays, adverse 
events, and hospital 
admissions 
Feasibility study: home telemonitoring for patients with 
lung cancer in a mountainous rural area 2014 Petitte, TM US Quasi Not defined Patients 10 0 10 Lung 
Enrollment and retention 
characteristics, symptoms, 
program satisfaction 
Identifying the readiness of patients in implementing 
telemedicine in northern Louisiana for an oncology 
















Improving access to specialist multidisciplinary palliative 
care consultation for rural cancer patients by 
videoconferencing: report of a pilot project 2013 
Watanabe, 




Medical oncology clinics through videoconferencing: an 
acceptable telehealth model for rural patients and health 
workers 2012 Sabesan, S Australia Mixed Not defined Multiple 68 0 68 Multiple Satisfaction 
Patient perceptions of a mobile cancer support unit in 
South Wales 2011 Iredale, R UK Mixed Not defined Patients 97 0 97 Multiple 
Quantitative and qualitative 
patient satisfaction 
Patients' experiences of receiving chemotherapy in 
outpatient clinic and/or onboard a unique nurse-led mobile 
chemotherapy unit: a qualitative study 2013 Mitchell, T UK Qual Not defined Patients 20 0 20 Multiple 
Thematic analysis of 
interviews 
Randomized controlled trial of a multisite speech 
pathology telepractice service providing swallowing and 
communication intervention to patients with head and 





Randomized trial of telegenetics vs. In-person cancer 
genetic counseling: cost, patient satisfaction and 
attendance 2015 
Buchanan, 
2015 US RCT Not defined Patients 162 0 162 Multiple 
Cost, satisfaction, 
utilization 
Remote chemotherapy supervision model for rural cancer 
care: perspectives of health professionals 2016 Jhaveri, D Australia Qualitative Not defined 
Healthcare 
providers 19 0 19 Multiple 
Thematic analysis of 
interviews 
Role of telehealth/videoconferencing in managing cancer 
pain in rural American Indian communities 2012 Haozous, E US Quasi Not defined 
Healthcare 
providers 52 0 52 Multiple 
Satisfaction and self-
perceived competence  
Safe introduction of laparoscopic colorectal surgery even 
in remote areas of the world: The value of a 
comprehensive telementoring training program 2015 Forgione, A 
Russia 
and Italy Quasi Not defined 
Healthcare 
providers 1 0 1 Colorectal Program evaluation 
Satisfaction with telehealth for cancer support groups in 
rural American Indian and Alaska Native communities 2010 
Doorenbos, 
AZ US Quasi Not defined Patients 32 0 32 Multiple Satisfaction, distance, time 
Telehealth in radiation oncology at the Townesville 
Cancer Centre: Service evaluation and patient satisfaction 2018 Hamilton, E Australia Quasi 
Distance from 
clinic Patients 311 0 311 Multiple 
Service evaluation, 
satisfaction 
Telemedicine for rural cancer care in North Queensland: 
bringing cancer care home 2012 Sabesan, S Australia Quasi Not defined Patients 158 0 158 Multiple Service provision 
Teleoncology for indigenous patients: the responses of 
patients and health workers 2012 Mooi, JK Australia Qual Not defined Multiple 15 0 15 Multiple Satisfaction 
Telepharmacy in a rural alberta community cancer 
network 2012 Gordon, HL Canada Mixed Not defined 
Healthcare 
providers 47 0 47 Multiple Utilization, satisfaction 
Timely access to specialist medical oncology services 
closer to home for rural patients: experience from the 
Townsville Teleoncology Model 2014 Sabesan, S Australia Quasi Not defined Patients 70 0 70 Multiple 
Time to specialist review, 
hospital transfers 
Using telehealth to train providers of a cancer support 
intervention 2015 
Brandon, 
AR US Mixed Not defined 
Healthcare 


















Using videotelephony to support pediatric oncology-
related palliative care in the home: from abandoned RCT 
to acceptability study 2009 
Bensink, 
ME Australia Quasi ARIA Multiple 10 7 17 Multiple 
Acceptability, QOL, 




The quality of cancer patient experience: perspectives of 
patients, family members, providers and experts 2010 Wagner, EH US Qual not defined Multiple -- -- 54 Multiple Barriers, facilitators  
The experiences of participants in an innovative online 
resource designed to increase regular walking among rural 
cancer survivors: a qualitative pilot feasibility study 2014 
Frensham, 
LJ Australia Qual not defined Patients 8 0 8 Multiple Feasibility, acceptability 
The consumer-driven development and acceptability 
testing of a website designed to connect rural cancer 
patients and their families, carers and health professionals 
with appropriate information and psychosocial support 2017 Fennel, KM Australia Mixed ARIA Multiple 111 0 111 Multiple 
Acceptability, perceived 
impact, utilization 
Reaching further with online education? The development 
of an effective online program in palliative oncology 2010 
Koczwara, 
B Australia Mixed Not defined 
Healthcare 
providers 90 0 90 Multiple Utilization and satisfaction 
Evaluation of cancerchatcanada: A program of online 
support for Canadians affected by cancer 2013 Stephen, J Canada Mixed 
Population 
size Multiple 77 274 351 Multiple Program evaluation  
Evaluating Adaptation of a Cancer Clinical Trial Decision 
Aid for Rural Cancer Patients: A Mixed-Methods 




self-efficacy, attitudes  
Engaging Stakeholders in the Development of an eHealth 
Intervention for Cancer Symptom Management for Rural 
Residents 2018 
Gilbertson-
White, S US Mixed 
Population 
size Multiple 26 0 26 Multiple Useability 
Engagement with INSPIRE, an Online Program for 
Hematopoietic Cell Transplantation Survivors 2018 Syrjala, KL US RCT 
ZIP codes 
using cms.gov 
categories Patients 95 356 451 Multiple Engagement, utilization 
Assessing cancer survivors' needs using web-based 
technology: a pilot study 2012 
Lavoie 




A qualitative evaluation of a group phone-based weight 
loss intervention for rural breast cancer survivors: Themes 
and mechanisms of success 2016 Fazzino, TL US Qual Not defined Patients 186 0 186 Breast 
Thematic analysis of 
interviews 
Change in Physical Activity During a Weight 
Management Intervention for Breast Cancer Survivors: 
Association with Weight Outcomes 2017 Fazzino, TL US Quasi 
Population 
density Patients 142 0 142 Breast Physical activity 
Outcomes of a weight loss intervention among rural breast 
cancer survivors 2012 Befort, CA US Quasi RUCA Patients 35 0 35 Breast 
Weight, diet, physical 

















Weight loss maintenance strategies among rural breast 
cancer survivors: The rural women connecting for better 
health trial 2016 Befort, CA US RCT RUCA Patients 172 0 172 Breast 
Weight loss maintenance, 
cost-effectiveness 
Cost-benefit analysis of decision support methods for 
patients with breast cancer in a rural community 2013 Wilson, L US RCT Not defined Patients 68 0 68 Breast 
Program delivery costs and 
willingness-to-pay 
Decision support by telephone: Randomized controlled 
trial in a rural community setting 2012 Belkora, J US RCT 
population 





Benefits of Early Versus Delayed Palliative Care to 
Informal Family Caregivers of Patients With Advanced 
Cancer: Outcomes From the ENABLE III Randomized 
Controlled Trial 2015 
Dionne-
Odom US RCT RUCA Multiple -- -- 122 Multiple 
QOL, depression and 
burden 
Adapting an Early Palliative Care Intervention to Family 
Caregivers of Persons With Advanced Cancer in the Rural 
Deep South: A Qualitative Formative Evaluation 2018 
Dionne-
Odom, JN US Qual RUCA Multiple 64 0 64 Multiple 
Thematic analysis of 
interviews 
Family Caregiver Depressive Symptom and Grief 
Outcomes From the ENABLE III Randomized Controlled 
Trial 2016 
Dionne-
Odom US RCT Not defined Multiple -- - 123 Multiple 
Depressive symptoms and 
complicated grief 
The project ENABLE II randomized controlled trial to 
improve palliative care for rural patients with advanced 
cancer: baseline findings, methodological challenges, and 
solutions 2009 Bakitas, MA US RCT RUCA Patients 147 132 279 Multiple 
Symptoms, QOL, mood, 
and functional status 
Early Versus Delayed Initiation of Concurrent Palliative 
Oncology Care: Patient Outcomes in the ENABLE III 
Randomized Controlled Trial 2015 Bakitas, MA US RCT RUCA Multiple -- -- 207 Multiple 
QOL, symptom impact, 
mood, 1-year survival, and 
resource use 
Mobile 
Developing NaviCanPlan: A Mobile Web Resource 
Locator for Cancer Providers and Survivors 2015 Dahlke, DV US Mixed Not defined Multiple -- -- 150 Multiple Needs assessment 
A Mobile Breast Cancer Survivorship Care App: Pilot 
Study 2017 Baseman, J US Qual Not defined Multiple 4 7 11 Breast 







Table 2. Comparison of digital health strategies across populations72 
  Rural Cancer 
(present 
study) 




Telephone n=11, 21% n=16, 24% n=17, 
16.5% 
n=15, 21% n=21, 24% 
Mobile apps n=2, 4% n=8, 12% n=25, 24% n=11, 15% n=7, 8% 
Internet n=9, 17% n=30, 45% n=29, 28% n=38, 52% n=13, 15% 























CHAPTER 3: Paper Two 
 
Geographic Differences in Sociodemographic and Clinical Factors Associated with 




Purpose. Nonadherence to cancer treatment is associated with higher rates of cancer recurrence 
or treatment failure and decreased survival. Rural cancer patients experience a 10% higher 
mortality rate compared with their nonrural counterparts; geographic differences in adherence 
may contribute to this increased mortality rate. Radiation treatment is both time and resource 
intense, making adherence especially challenging. The goal of this study was to determine 
sociodemographic and clinical factors associated with radiation treatment nonadherence among 
rural and nonrural cancer patients. 
 
Methods and materials. We utilized cancer registry and hospital billing claims data to measure 
radiation treatment nonadherence, defined as at least 2 missed appointments, among cancer 
patients at least 18 years of age who received their first line radiation treatment course at our 
academic medical center. Geography was based on USDA 2013 Rural-Urban Continuum Codes, 
and patient age, race, sex, cancer type, cancer clinical stage, radiation treatment modality, and 
insurance type were included as covariates. We used multivariable logistic regression to estimate 
odds ratios, 95% Wald confidence intervals, and Wald p-values. 
 
Results. We identified 2161 cancer patients who met the study eligibility criteria, with 15% 
living in a rural area. Patients had an average of 20 treatment appointments and 25% of patients 
missed at least 2 appointments. Rural patients were more likely to have stage 4 disease than their 
nonrural counterparts. Rural cancer patients who lacked health insurance and who had more 
appointments were more likely than nonrural patients to be nonadherent, with the odds of 
nonadherence increasing by 14% with each additional appointment (OR 1.14, 95% CI 1.09-
1.20). Patients with clinical stage 4 cancer also had an increased odds of being nonadherent.  
 
Conclusions. This analysis revealed actionable clinical implications, identifying geographic 
disparities and specific patient population subsets in need of additional treatment adherence 
support. Major factors that contribute to missed radiation therapy appointments included total 
number of scheduled appointments, advanced cancer stage and insurance status.  Based on these 
results, large catch-net hospitals may want to consider offering more hypofractionated treatment 







Despite improvements in prevention and treatment, cancer remains a leading cause of death in 
the United States.1 Over 1.7 million people were diagnosed with cancer in 2019, with more than 
600,000 cancer deaths. Nonadherence to cancer treatment is associated with higher rates of 
cancer recurrence or treatment failure and decreased survival.9–16 Reports of mortality have been 
up to four times as likely in nonadherent compared with adherent patients. Treatment adherence 
represents a modifiable risk factor that can be targeted to directly improve cancer outcomes.  
 
Radiation therapy is a mainstay of cancer treatment for many cancer types, yet treatment 
adherence is especially challenging in this context since most treatment plans with curative intent 
involve daily radiation for up to 8 weeks. Interruptions to the schedule, such as missed 
appointments, are thought to reduce treatment efficacy by allowing additional time for the tumor 
cells to repopulate.141,142 With conventional fractionation, even one missed appointment could 
reduce the local control rate by about 1.4%, regardless of the fractionation schedule and primary 
tumor site.143  
 
Treatment nonadherence has been measured in a variety of ways in the literature, yet results have 
consistently documented it as a significant predictor of poorer clinical outcomes. Studies 
examining specific tumor subsets have included head and neck, cervical, prostate, lung and 
breast cancer.19,21,143–145 Defining nonadherence as a >14 day treatment interruption, patients 
with advanced head and neck cancer had a nonadherence rate of 35%, and nonadherence was 
significantly associated with persistent regional disease.144 Defining nonadherence as 
interruptions in the treatment schedule resulting in increased overall treatment time yielded 
similar results in tumor control and survival for patients with invasive carcinoma of the uterine 
cervix.18,19 Recent studies of patients with high-risk prostate cancer found similar evidence, with 
nonadherence - defined as missing 3+ days in the planned treatment course - predicting poorer 
overall survival.145 In lung cancer patients, treatment interruption 5+ days has shown 
significantly worse local control and survival outcomes.143 Even in patients treated adjuvantly, 
such as in post-operative radiation for breast cancer, treatment interruptions >5 days impacted 
local control and interruptions >8 days reduced both local control and overall survival.21  
 
Recognizing the importance of radiation treatment adherence on tumor control and survival in a 
variety of cancers, Ohri et al. sought to identify significant predictors of nonadherence within a 
nonrural patient population.142 The team examined 7 of the most commonly treated malignancies 
and considered nonadherence to be missing two or more scheduled radiation therapy 
appointments. 20% of patients were classified as nonadherent. Significant predictors of 
nonadherence were diagnoses of head and neck, cervical, or uterine cancer, treatment during the 
winter months, low socioeconomic status, and longer treatment course. Within the same nonrural 
patient population, the team identified that this strict definition of nonadherence (2+ missed 
appointments) was associated with poorer outcomes (recurrence, recurrence-free survival, and 
overall survival.17 
 
Geographic differences in adherence between rural and nonrural cancer patients have been cited 
as a possible reason for disparities in cancer outcomes.10,20,41,146–148 A growing set of studies have 
begun to document that cancer treatment adherence is poorer among rural populations.13,20,39–
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46,146–151 Rural residents are more likely to have lower educational attainment, higher poverty 
rates and are more likely to report treatment-related financial hardship than their nonrural 
counterparts, all of which may affect treatment adherence.22,24 A number of studies have shown 
that lower health literacy is related to poor medication adherence.23,25 With regard to financial 
distress, prior studies have shown that the degree to which treatment has created a financial 
burden is associated with medication nonadherence.24,25 Specifically, investigators found that 
nearly half of participants reported experiencing some form of financial distress and did not 
adhere to recommended prescription medication because of cost. Rural populations also have a 
higher proportion of elderly residents, who are more likely to be diagnosed with cancer and are 
at greater risk for polypharmacy issues and medication treatment nonadherence.22,30,152 
 
An increasing number of studies are considering cancer treatment nonadherence in rural 
populations, with a particular focus on treatment guideline concordance;13,39–45,149 however, none 
to-date have considered geographic disparities in radiation treatment nonadherence. The goal of 
this study was to determine sociodemographic and clinical factors associated with radiation 
treatment nonadherence among rural and nonrural cancer patients using cancer registry and 
healthcare claims data. We hypothesized that geography would play a significant role in 






This study utilized the institution's hospital cancer registry and billing claims data. Eligibility for 
selection included patients of any cancer diagnosis at least 18 years of age who completed their 
full course of first line radiation therapy at the medical center between 1/1/2013 and 
12/31/2017. Exclusion criteria were incarcerated patients and any patient whose treatment had 
not yet ended (to calculate treatment adherence).  
 
Measures 
The outcome of interest was radiation treatment nonadherence. Radiation treatment visits 
included all unique treatment appointments. Missed appointments were scheduled appointments 
to which the patient did not cancel and did not attend. Canceled appointments were classified as 
those that were canceled by the patient prior to the appointment but not rescheduled. The 
‘canceled’ category did not include appointments canceled by the medical team. We treated 
nonadherence as a binary variable, classifying patients as either missing or canceling 0/1 
appointments or 2+ appointments.17,142 
 
The exposure of interest was rurality based on USDA 2013 Rural-Urban Continuum Codes 
[RUCC].153 Within the RUCC classification, metropolitan or ‘metro’ areas are defined as broad 
labor-market areas that include central counties with one or more urbanized areas that are 
densely populated with 50,000 or more people [RUCCs 1-3]. Nonmetro areas are outside the 
boundaries of metro areas [RUCCs 4-9].154 RUCCs were obtained by matching patient ZIP codes 
at time of diagnosis to their corresponding FIPS codes. FIPS codes were then matched to the 
2013 USDA RUCCs. In the present analysis, RUCCs 1-3 were categorized as ‘nonrural’ and 
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RUCCs 4-9 as ‘rural’. Two patients were missing ZIP codes, precluding RUCC assignment, so 
these patients were excluded from the analysis.  
 
Additional covariates extracted from the hospital cancer registry included patient age, race, sex, 
cancer type, cancer clinical stage at diagnosis, radiation treatment modality, and insurance type. 
Cancer types were categorized as breast, gastrointestinal, genitourinary, head and neck, and 
respiratory based on the codes assigned by the cancer registry. 
 
Analyses 
Descriptive analyses were first performed using means, standard deviations and two-sample t-
tests for continuous variables and counts, proportions, and Chi-square tests for categorical 
variables. A multivariable logistic regression model including all covariates and interaction terms 
was generated. Backwards elimination was used to sequentially remove factors not related to the 
outcome to create the most parsimonious model with the exit criteria set equal to the significance 
level (0.05). Odds ratios, 95% Wald confidence intervals, and Wald p-values were estimated, 




Table 1 summarizes the sample characteristics of the patient population contributing to the 
present analysis. Weidentified 2161 cancer patients who met the study eligibility criteria, with 
15% living in a rural area. While 26% of nonrural patients were classified as nonadherent versus 
19% of rural patients (p=0.02), rural patients had significantly fewer total appointments than 
nonrural patients (mean 18 vs 20, p=0.002). Patients missed an average of 2.6 appointments and 
12% of their treatment, with no significant geographic differences.  
 
Rural patients were older (mean=64 vs 62, p=0.02) and more likely to be male (49% vs 43%, 
p=0.03) than their nonrural counterparts. There were significant geographic differences by 
insurance type, with rural patients more often having Medicare and nonrural patients more often 
having commercial insurance (p<0.0001). Rural patients were more likely to have stage 4 disease 
than nonrural patients (32% vs 26%, p=0.02). A higher proportion of breast cancer patients 
resided in nonrural areas (33% vs 20%, p<.0001). There were no significant geographic 
differences by average or proportion of missed/cancelled appointments, race, and radiation 
treatment type in univariate analyses.  
 
Table 2 presents the final multivariable model of radiation treatment nonadherence while Figure 
1 depicts corresponding odds ratios and 95% confidence intervals. Geography, total number of 
treatment appointments, clinical stage, and insurance type were significant predictors of 
treatment nonadherence, controlling for cancer type. The model suggested a significant 
interaction between geography and the total number of appointments (p=0.001). While an 
increasing number of total treatments increased the odds of nonadherence across all geographic 
categories, rural uninsured patients had the highest increased odds. Specifically, the odds of 
nonadherence increased by 14% with each additional appointment for rural uninsured patients. 
Patients with clinical stage 4 cancer had a 90% increased odds of being nonadherent compared 






The goal of this study was to determine sociodemographic and clinical factors associated with 
radiation treatment nonadherence among rural and nonrural cancer patients using cancer registry 
and healthcare claims data. We hypothesized that geography would play a significant role in 
radiation treatment nonadherence, which indeed our data supported. Specifically, we found that 
geography, total number of treatment appointments, insurance type and clinical stage were 
significant positive predictors of treatment nonadherence. We also hypothesized that rural cancer 
patients would be less adherent to their radiation treatment than nonrural patients. This result 
turned out to be more nuanced and directly influenced by the number of treatments, with a 
geographic disparity resulting from an increasing number of treatment appointments and 
insurance type. 
 
Rural patients, especially those who lacked health insurance, who had more total treatments were 
more likely to be nonadherent, translating to the odds of nonadherence increasing significantly 
with each additional appointment. This finding may be indicative of an access to care issue, 
including financial toxicity, which may be encountered as the number of treatment appointments 
increase. Rural residents are more likely to have higher poverty rates and are more likely to 
report treatment-related financial hardship, which may affect treatment adherence.22,24,25,30 Prior 
studies have shown that the degree to which treatment has created a financial burden is 
associated with medication nonadherence.23–25 While we were not able to include a robust 
measure of financial toxicity in this secondary analysis, we did find that insurance type, which 
can contribute to financial toxicity,155 exerted a significant effect on treatment nonadherence. 
While there is a paucity of literature examining financial toxicity among patients treated with 
radiation therapy, this treatment type has been identified as a predictor of financial toxicity 
among cancer survivors.25 Additionally, patients diagnosed with stage 4 cancer were more likely 
to be nonadherent compared with patients presenting with stage 1 disease. Fatalistic views of 
cancer or cancer fatalism, ‘the belief that death is inevitable when cancer is present’, can result in 
lower cancer screening and delayed care seeking behaviors and increase the risk of a late stage 
cancer diagnosis.156,157 While we did not find a significant interaction effect between geography 
and stage, this finding still has implications for rural patients given they are more likely to be 
diagnosed with Stage 4 cancer. 158 
 
Our study population had similar sample characteristics to those previously reported, with 
approximately 15% living in a rural area and rural patients being older. Distribution of cancer 
diagnoses and clinical stage are also similar to those in the literature, with a higher proportion of 
breast cancer patients residing in nonrural areas and a higher proportion of gastrointestinal and 
genitourinary cancer patients residing in rural areas.158 Also similar to previous reports, a higher 
proportion of patients in rural areas were initially diagnosed with Stage 4 cancer than in nonrural 
areas.158 In a geographically diverse sample population of cancer survivors, we found a 
nonadherence rate of 2 or more missed/cancelled appointments to be 25%. That is similar to the 
20% nonadherence rate previously reported in a nonrural population with the same definition of 
nonadherence.142 
 
It is important to recognize this study’s strengths and limitations. While our analysis was derived 
from a secondary data source, we were able to utilize both cancer registry data and hospital 
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billing claims, resulting in a large database with a mix of cancer diagnoses and increasing our 
confidence in the accuracy of the appointment dates and completeness used to define 
nonadherence over self-reported information. There may be bias inherent in this data, since 
patients with the means necessary to attend at least a portion of their radiation treatment 
appointments in a nonrural academic setting comprised our dataset. We do not have data on 
patients who chose not to receive radiation treatment at our cancer facility or chose a different 
treatment modality, perhaps due to access limitations or treatment frequency requirements. 
While we utilized a literature-supported definition of nonadherence, we did not differentiate 
between appointments missed during treatment and early treatment discontinuation, which could 
have disparate implications for patient outcomes. Lastly, while we were able to consider health 
insurance in our analysis, as a secondary data analysis of hospital data we did not have access to 
other more nuanced measures that could influence nonadherence such as more complete 
measures of financial toxicity. 
 
This analysis revealed actionable clinical implications. Uninsured rural patients with more total 
treatment appointments were more likely to be nonadherent, as well as those with stage 4 
disease. In recognition of this finding, the healthcare team can focus on risk stratification based 
on insurance type and clinical stage; identifying key access barriers for each patient, or adopting 
additional assessments of barriers to care for this patient population; offering additional support 
resources; and scheduling a check in halfway through the treatment plan to support treatment 
adherence. The evidence-based practice of shorter radiation treatment regimens should continue 
to be considered.159 While we were able to identify key contributors to radiation treatment 
nonadherence, we were limited to cancer registry and hospital billing claims data. Future studies 
could benefit by including social and behavioral measures that may influence adherence, like 





Table 1. Summary of patient sample population characteristics 
 


















Total 2161  329 15.2 1832 84.8 <0.0001* 









0.1 0.1 0.1 0.2 0.1 0.1 0.2 
Age 62.2 11.9 63.6 11.8 61.9 11.9 0.02* 
Nonadherence       0.02* 
0/1 appts 1630 75.4 265 80.6 1365 74.5  
2+ appts 531 24.6 64 19.4 467 25.5  
Sex       0.03 
Female 1213 56.1 167 50.8 1046 57.1  
Male 948 43.9 162 49.2 786 42.9  
Race       0.66 
White 1383 64.0 207 62.9 1176 64.2  
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Black 778 36.0 122 37.1 656 35.8  
Insurance       <.0001* 
Medicare 973 45.0 179 54.4 794 43.3  
Commercial 734 34.0 67 20.4 667 36.4  
Medicaid 155 7.2 28 8.5 127 6.9  
Uninsured 244 13.3 55 16.7 244 13.3  
Clinical stage       0.02 
1 572 26.5 67 20.4 505 27.6  
2 566 26.2 87 26.4 479 26.2  
3 447 20.7 69 21.0 378 20.6  
4 576 26.7 106 32.2 470 25.7  
Cancer Site       <.0001* 
Breast 676 31.3 67 20.4 609 33.2  
Gastrointestinal 279 12.9 48 14.6 231 12.6  
Genitourinary 174 8.1 38 11.6 50 2.7  
Gynecologic 67 3.1 17 5.2 50 2.7  
Head and Neck 355 16.4 55 16.7 300 16.4  
Hematology 61 2.8 9 14.8 52 2.8  
Respiratory 549 25.4 95 28.9 454 24.8  
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Treatment Type       0.3 
Conformal 
Therapy 
294 13.6 51 15.5 243 13.3  
External Beam 1191 55.1 169 51.4 1022 55.8  
IMRT 531 24.6 82 24.9 449 24.5  
SRS 145 6.7 27 8.2 118 6.4  




Table 2. Multivariable model of treatment nonadherence, controlling for cancer type 
 
 Estimate SE Chi-Square P-value 
Intercept -4.21 0.24 307.0 <.0001 
Total appts 0.12 0.007 292.7 <.0001 
Geography  
(ref = Nonrural [RUCC 1-3]) 
    
Rural [RUCC 4-9] -0.22 0.10 4.73 0.03 
Insurance (ref = Medicare)     
Commercial -0.37 0.16 5.47 0.02 
Medicaid 0.05 0.21 0.06 0.8 
Uninsured 0.35 0.16 4.87 0.03 
Total appt x Insurance  x 
Geography interaction 
    
Total appts -  
Rural, Commercial 
-0.09 0.01 0.75 0.39 
Total appts - 
Rural, Medicaid 
-0.01 0.01 1.71 0.19 
Total appts - 
Rural, Uninsured 
0.01 0.01 4.80 0.03* 
Clinical stage (ref = 1)     
2 0.09 0.11 0.68 0.41 
3 -0.09 0.12 9.89 0.002* 



























CHAPTER 4: Paper Three 
 






Nonadherence to cancer treatment is associated with higher rates of cancer recurrence or 
treatment failure and decreased survival. A growing set of studies have begun to document that 
cancer treatment adherence is poorer among rural populations. Information-Motivation-
Behavioral Skills theory assumes that health-related information, motivation, and behavioral 
skills are fundamental determinants of performance of health behaviors, while the Chronic Care 
Model highlights the interdependent importance of self-management support, delivery system 
design, decision support, and clinical information systems to support patients and their care 
providers in having productive interactions and improved patient outcomes. Despite their utility, 
evidence of theory-driven approaches is limited in cancer treatment nonadherence literature to-
date. 
Purpose 
Treatment adherence represents a modifiable risk factor that can be targeted to directly improve 
cancer outcomes. Multilevel factors contribute to cancer treatment nonadherence yet have not 
been fully investigated. The purpose of this study was to delineate social and behavioral 
determinants of rural cancer treatment nonadherence using a mixed method approach. The 
combined Information-Motivation-Behavioral Skills-Chronic Care Model provided the 
theoretical foundation for the design of the present study and interpretation of results. 
Methods 
We conducted a sequential explanatory mixed methods study among rural cancer survivors, 
classified by RUCC 4-9, and nonrural survivors who completed first-line cancer treatment in the 
past five years. Potential participants were randomly selected from the Cancer Center survivor 
database. Rural participants who agreed in the survey to be recontacted and provided either a 
phone number or email were recruited for the rural cancer-focused interviews. We utilized 
cancer registry and hospital billing claims data to define treatment nonadherence (2+ missed 
appointments), geography based on USDA 2013 Rural-Urban Continuum Codes, and the 
additional covariates based on survey measures of the Information-Motivation-Behavioral Skills 
Chronic Care Model and sociodemographics. We used multivariable logistic regression to 
estimate odds ratios, 95% Wald confidence intervals, and Wald p-values. Interpretative 
phenomenological analysis was used to gain insight into how cancer survivors experience the 





Survey efforts resulted in 430 participants (188 rural and 242 nonrural cancer survivors). Rural 
cancer survivors reported lower levels of educational attainment and income (p=0.005 and 0.003, 
respectively). Rural cancer survivors reported higher levels of spiritual coping and expressed a 
more fatalistic view of cancer than nonrural survivors (p=0.04 and p=0.01, respectively), which 
was also expressed in individual interviews. Nearly half (47%) of rural cancer survivors said it 
was somewhat or very hard to pay for transportation to treatment appointments, compared with 
only 19% of nonrural participants (p<0.0001). Additionally, 37% of rural cancer survivors 
reported that accessing transportation for treatment appointments was somewhat or very hard, 
compared with only 17% of nonrural participants (p<0.0019). Interview participants described 
the importance of care coordination with local clinics or access to academic medical center 
satellite clinics for reducing transportation burden. Rural cancer survivors were significantly less 
likely to seek health information online, to access their online medical record, and reported 
accessing electronic health information to be significantly more challenging (p=0.001, p=0.01, 
and p=0.0008, respectively). Reasons for this were described by interview participants as related 
to lack of internet access or slow data transfer speeds, or reliance on family members to perform 
online functions. In multivariable logistic regression, increasing barriers to transportation were 
significantly associated with treatment nonadherence (p=0.02; OR: 1.56, CI: 1.09-2.24). The 
interaction between geography and the behavior skill of bringing a list of questions to a clinic 
appointment was significant, with rural cancer survivors who do not bring a list of questions to 
appointments having over 3 times greater odds of being nonadherent (p=0.05; OR: 3.37, CI: 
1.02-11.14). Interview participants highlighted challenges in question generation, a behavioral 
skill that could be supported by the healthcare system. 
  
Conclusions 
The factors identified in this study provide theory-based opportunities for interventions designed 
to improve treatment adherence among rural populations. Rural cancer survivors face significant 
barriers to transportation for treatment appointments and lack important skills for patient 
engagement. Addressing transportation barriers and supporting appointment preparation could 






Despite improvements in prevention and treatment, cancer remains a leading cause of death in 
the United States.1 The nearly 3 million US cancer survivors residing in rural areas experience 
10% higher cancer mortality compared to their nonrural counterparts.3 Nonadherence to cancer 
treatment is associated with higher rates of cancer recurrence or treatment failure and decreased 
survival.9–16 The interaction of individual, community and health system-level factors, with 
unique aspects likely associated with the observed disparities between rural and nonrural 
populations, contributes to cancer treatment nonadherence. To-date there has been little attention 
to factors that might help explain treatment nonadherence among rural cancer patients, and prior 
research has lacked a unifying theoretical approach to framing how factors at multiple levels 
contribute to nonadherence among rural populations. A better explanation of these factors and 
how they interact can guide novel, theory-based strategies to improve treatment adherence 
among rural populations.  
A growing set of studies have begun to document that cancer treatment adherence is poorer 
among rural populations.9–16,39–46 Most of these studies (11/16) were conducted among breast 
cancer patients. Only 3 studies involved qualitative methods (2 interview-based studies and 1 
focus group-based study);39,42,43 the remaining 13 articles relied on quantitative data sources. 
Only 1 study involved a prospective survey, which was limited by sample size (N=31).47 The 
other 12 studies utilized secondary data sources largely consisting of healthcare claims data. 
There were no studies identified that employed mixed methodology, which would provide rich 
insight into factors contributing to nonadherence. Evidence of theory-driven approaches was 
even more limited, with only one manuscript describing a theoretical model or framework 
guiding the study development.9 Treatment nonadherence represents a modifiable risk factor that 
can be targeted to directly improve cancer outcomes, yet successful interventions may require a 
theoretically-driven, multilevel approach. 
The Theory Derivation process, the structured set of procedures in which a parent theory or 
model is used to guide the development of a new model or theory in conjunction with a 
comprehensive review of the current literature, was employed to understand how potential 
factors related to treatment nonadherence may fit together and influence outcomes in rural 
populations.48 We considered two parent theories: the Information-Motivation-Behavioral Skills 
Theory (IMB) and the Chronic Care Model (CCM). 
 
IMB posits that individuals who are well-informed about a behavior, motivated to act on that 
behavior, and possess the behavioral skills required to act effectively in support of that behavior, 
will likely initiate and maintain patterns of the target behavior.51 The IMB model specifies that 
the effects of health promotion information and motivation are seen primarily as a result of the 
application of health promotion behavioral skills to the initiation and maintenance of health 
promotion behavior.49 While the IMB model was originally established in HIV risk behavior 
interventions, it is viewed as a generalizable approach to understanding and promoting health 
behavior more broadly.49 For example, it has been successfully applied to smoking cessation 
interventions,52 interventions to increase physical activity,53 breast self-examination 




While IMB theoretically accounts for the individual level, multilevel factors contribute to cancer 
treatment nonadherence. The Chronic Care Model is a well-established and validated framework 
that positions chronic care in the context of community, with observation, intervention, and 
evaluation studies focused on organizational characteristics, quality improvement, and cost 
effectiveness to benefit patients with congestive heart failure, asthma, and diabetes.50,57 The 
model highlights the interdependent importance of self-management support, delivery system 
design, decision support, and clinical information systems to support patients and their care 
providers in having productive interactions and improved patient outcomes. A benefit to this 
model is its flexibility acts more as a framework than a packaged intervention, allowing 
researchers to tailor CCM elements to individual organizations, yet it lacks patient-level factors 
that influence care delivery. 
While both the IMB and the CCM have demonstrated utility in health promotion and quality 
improvement, neither fully capture the multilevel factors relevant to adherence in rural cancer 
survivors. Bringing the IMB and the CCM together as the Information-Motivation-Behavioral 
Skills theory - Chronic Care Model (IMB-CCM; Fig. 1) provides a more complete framework 
from which to study and address treatment nonadherence in rural cancer survivors. IMB-CCM 
identifies that receipt of information during the cancer journey is necessary but not sufficient to 
achieve positive behavioral and health outcomes like treatment adherence and survival. In 
addition, behavioral skills to promote self-management through patient engagement, along with 
personal and social motivation shaped by rural culture, information access and information 
utilization, are critical determinants. Individual, community and health system-level factors 
interact to influence outcomes, with unique aspects likely associated with the observed 
disparities between rural and nonrural populations. The combined IMB-CCM provided the 
theoretical foundation for the design of the present study and interpretation of results. The 
purpose of this study is to delineate social and behavioral determinants of rural cancer treatment 
nonadherence. A theory-driven mixed methods study design was employed to directly assess 
constructs hypothesized to be related to treatment nonadherence and then results explored 
through in-depth interviews with rural oncology survivors and caregivers. 
METHODS 
Study Design. We conducted a sequential explanatory mixed methods study160 in which first 
conducted a survey of rural and nonrural cancer survivors, with survey results informing the 
qualitative interview guide, and the interview perspectives providing an enhanced understanding 
of the survey results. The IMB-CCM was used to inform survey and interview development to 
systematically generate data that would more fully explain factors contributing to treatment 
nonadherence in rural oncology.  
Population. Rural cancer survivors, classified by USDA 2013 Rural-Urban Continuum Codes 
(RUCC)153 4-9, and nonrural survivors who completed first-line cancer treatment in the past five 
years at our academic medical center were eligible for the study. 1050 rural and 1050 nonrural 
potential participants were randomly selected from the hospital’s cancer registry out of the 1091 
rural and 6012 nonrural eligible cancer survivors. After individuals from the same household and 
bad addresses were removed, 961 surveys were mailed to rural survivors and 1037 surveys were 
mailed to nonrural survivors in December 2019 (Paper 3 Appendix 1). Survey participants who 
also consented to study team access to their medical records were included in the present 
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analysis to allow for calculating treatment adherence. Rural participants who agreed in the 
survey to be recontacted and provided either a phone number or email were recruited for the 
rural cancer-focused interviews. 
Survey design and administration. Valid and established measures in the field were included to 
assess study constructs. Per the Tailored Design Method, surveys are written in large font with 
clear instructions for answering each survey item and more interesting questions at the front of 
the survey to promote engagement. Surveys were mailed according to the Dillman method to 
increase response rate. These standard survey methods were used to reduce bias in response.  
Survey measures and constructs assessed were selected based on IMB-CCM and included: 
Seeking health information, seeking health information online as the first source of information, 
and electronic information accessibility (Information); medical distrust, cancer fatalism, spiritual 
coping, and transportation barriers (Motivation); appointment preparation, and engagement in 
during and outside an appointment (Behavioral skills); social support (Community); and 
accessing their online medical record, using an app to communicate with a healthcare provider, 
and patient-provider communication (Health systems). The sociodemographic variables of age, 
race, sex, education, income, cancer clinical stage, insurance type were also included. 
IMB Constructs 
Information: Seeking health information was assessed by, “Have you ever looked for 
information about health or medical topics from any source?” (Yes/No) The measure of 
seeking health information online as the first source of health information was derived 
from the follow-up question, “The most recent time you looked for information about 
health or medical topics, where did you go first?” with “internet” as one of the choices.161 
The Electronic Info Accessibility Score was constructed as a summary scale of four 
Likert-type questions with responses ranging from strongly agree to strongly disagree 
(Cronbach’s alpha = 0.83). The questions were: Based on your most recent search for 
information about health, how much do you agree or disagree with each of the following 
statements? 1) It took a lot of effort to get the information you needed; 2) You felt 
frustrated during your search for information; 3) You were concerned about the quality of 
information; 4) The information you found was hard to understand.79 Responses were 
summarized such that higher scores indicate easier perceived accessibility of online 
information. 
Motivation: Medical distrust was measured as a single item, How much do you trust 
information about cancer from a doctor? ranging from not at all to a lot.161 Cancer 
fatalism was measured as a single item, There’s not much you can do to lower your 
chances of getting cancer, ranging from strongly agree to strongly disagree.161 Medical 
distrust was dichotomized as Not at all/A little and Some/A lot. Cancer fatalism was 
dichotomized as Strongly agree/Somewhat agree and Somewhat disagree/Strongly 
disagree. 
The Spiritual Coping Score consisted of three Likert-type questions with responses 
ranging from, I haven’t been doing this at all to I’ve been doing this a lot (Cronbach’s 
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alpha = 0.85). The questions were: I’ve been trying to find comfort in my religion or 
spiritual beliefs; I’ve been praying or meditating; and I’ve been going to church or church 
activities.162 Responses were summarized such that higher scores indicate more spiritual 
coping practices. 
The Transportation Barriers Score developed by the study investigators consisted of 3 
Likert-type questions with responses ranging from Very Easy to Very Hard (Cronbach’s 
alpha = 0.73). Leading with “Imagine you are receiving treatment for a disease at your 
preferred hospital. If you needed to go to the hospital for this treatment 5 days a week for 
6 weeks, with each appointment lasting about 30 minutes, how easy or hard would it be 
for you to:” and then following with “Have a way to get to the hospital? Examples may 
be you driving, someone else driving you, taking a bus, taking a train, biking, walking?”, 
“Pay for transportation to the hospital? Examples may be paying for gas, a train ticket, a 
bus pass, parking”, “Take time off or afford time off from work for these appointments?” 
Responses were summarized such that higher scores indicate more perceived barriers to 
transportation for treatment appointments. 
Behavioral skills: Survey items related to behavioral skills consisted of appointment 
preparation and patient engagement. Responses options ranged from Never to Always; 
however, we chose to dichotomize the responses as Never/Sometimes and 
Usually/Always. Questions led with “In general, how often do you…” asked: 1) take with 
you to your doctor visits a list of questions; 2) take a list of all your prescribed medicines 
to your doctors visits; 3) ask your doctor to explain a test, treatment or procedure to you 
in detail; 4) read information about a new prescription, such as side effects and 
precautions; 5) do your own research on a health or medical topic after seeing your 
doctor; 6) take with you to your doctor visit any kind of  information you found.161 
CCM Constructs 
Community: The Social Support Score included 6 Likert-type questions with responses 
ranging from Never to Always: 1) Is there anyone you can count on to provide you with 
emotional support when you need it, such as talking over problems or helping you make 
difficult decisions? 2) Do you have friends or family members that you talk to about your 
health? 3) Do you have someone to prepare your meals if you are unable to do it 
yourself? 4) Do you have someone to take you to the doctor if you need it? 5) Do you 
have someone to help you with daily chores if you are sick? 6) Do you have someone to 
run errands if you need it?161 Responses were summarized such that higher scores 
indicate better perceived social support (Cronbach’s alpha = 0.90). 
Health Systems: 
Accessing their online medical record was measured by the survey question, “Have you 
ever looked at your medical records online?” (Yes/No) 
The measure of Using an app to communicate with a healthcare provider was derived 
from the question, “Have you ever used any ‘health-related app’ that tracks your behavior 
(such as exercise, diet, or sleep); reminds you to take medication or drink water; helps 
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you stay calm or meditate; or gives health information or advice? Mark all that apply.” in 
which the response “Communicating with my doctor or other provider” was selected. 
Patient-provider communication was measured by a 7-item Likert scale with responses 
ranging from Always to Never (Cronbach’s alpha = 0.91). The scale led with, “The 
following questions are about your communication with all doctors, nurses or other 
health professionals you saw during the past 12 months. How often did they…1) Give 
you a chance to ask all the health-related questions you had? 2) Give the attention you 
needed to your feelings and emotions? 3) Involve you in decisions about your health care 
as much as you wanted? 4) Make sure you understood things you needed to do to take 
care of your health? 5) Explain things in a way you could understand? 6) Spend enough 
time with you? 7) Help you deal with feelings of uncertainty about your health or health 
care?161 Responses were reverse coded then summarized such that higher scores indicate 
better perceived patient-provider communication. 
Interview design and administration. Interviews were conducted in-person or by phone, with 
the location and time selected at the convenience of the participant. All interviews began with 
describing the study as an effort to “better understand the challenges you may have faced and the 
resources you have had during your cancer journey as a rural resident”. The interviewer then 
went on to thank the participant for his or her time, reminded them that participation in the 
interview was voluntary, and that the interviews would be audiorecorded. 
The opening set of questions asked for the participant to describe their community and their 
perceptions of rurality. Topics within the semi-structured interview guide considered experiences 
with the overall cancer journey, social support, healthcare access, finances, treatment adherence 
and engagement, medical distrust, shared decision-making, support services, clinical trials, and 
information access. Interview guide questions are listed in Paper 3 Appendix 2. Interviews were 
audio-recorded, with recording times ranging from 40 to 84 minutes. Participants received $20 
upon completion of the interview. 
Analysis. Response and refusal rates were calculated based on Response Rate 1 and Refusal 
Rate 1 of the American Association for Public Opinion Research Standard Definitions. Summary 
scales were assessed for internal consistency with Cronbach’s alpha. We described our study 
population using means, standard deviations and two-sample t-tests for continuous variables and 
counts, proportions, and Chi-square tests for categorical variables. The outcome variable was 
treatment nonadherence, defined as 2 or more missed or cancelled treatment appointments. A 
multivariable logistic regression model including all covariates and interaction terms was 
generated. Backwards elimination was used to sequentially remove factors not related to the 
outcome to create the most parsimonious model with the exit criteria set equal to the significance 
level (0.05). Odds ratios, 95% Wald confidence intervals, and Wald p-values were estimated. All 
quantitative data analysis was conducted using SAS version 9.4. 
Interpretative phenomenological analysis (IPA) was used to analyze the interviews. This 
methodology was selected because of its emphasis on describing a “common meaning for several 
individuals of their lived experiences of a concept or phenomenon”.163 IPA most frequently 
draws on accounts of an average of 6 interview participants, although 3 to 15 participants is 
acceptable.164 Significant statements were selected that “provide an understanding of how 
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participants experienced the phenomenon,” in this case, the cancer journey as a rural resident, 
through a process called horizontalization.163 
RESULTS  
 
Survey efforts concluded at the end of January 2020 and generated a 22% response rate (20% in 
rural, 23% in nonrural)(Paper 3 Appendix 1). Completing the survey by mail was the preferred 
method in this population, though 21% opted to complete the survey online. Refusal rates were 
3% for both rural and nonrural residents. There were 188 rural participants and 242 nonrural 
participants, for a total of 430 participants. Participants who provided HIPAA consent for 
accessing medical records were more likely to be White, more educated and with higher incomes 
than participants who did not provide HIPAA consent (Table 1). Participants who did and did not 
provide HIPAA consent did not significantly differ by age, geography, gender, or insurance type 
(all p-values > .05). 
 
Table 2 presents the study sample's key characteristics by geographic residency. Rural 
participants were on average 85 minutes from their usual source of cancer care versus 32 minutes 
for nonrural participants (p<0.0001). Rural cancer survivors reported lower levels of educational 
attainment and income (p=0.005 and 0.003, respectively). Insurance type differed by geography, 
with a higher percentage of nonrural participants reporting commercial insurance and rural 
participants reporting Medicaid (p=0.03). 
 
Table 3 describes rural-nonrural differences in the IMB-CCM constructs. Rural cancer survivors 
were significantly less likely to seek health information online as their first information source 
and to access their online medical record (p=0.001 and 0.001, respectively. When talking about 
seeking health information online, Participant 2 said, “I’m not one to do that but my wife is,” 
reflecting the support system involvement with obtaining health and cancer-related information. 
 
Accessing electronic health information was deemed significantly more challenging for rural 
cancer survivors than nonrural survivors (p=0.0008). Interview participants emphasized how 
expensive and slow the internet is in their areas:  
“Slow! Well, of course the more you pay the faster your internet, and our bill had gone 
up so high I thought to myself something’s gotta go…so I went to the cheaper plan, but it 
is slow.” (Participant 1)  
 
Survey participants in rural areas expressed a more fatalistic view of cancer than nonrural 
survivors (p=0.01). Cancer fatalism was also highlighted in the rural cancer interviews. One 
caregiver, when speaking of her husband’s reaction to his stage 2 cancer diagnosis, said,  
“In his mind, they had just signed his death [sentence]. He had only maybe months to 
live. Cuz on the way home from VCU, I was driving, and um, just out of the clear blue, 
he says, well I reckon I might as well go ahead and sell my boat now. And to me, that 
was, he’s already given up.” (Participant 1) 
 
Rural cancer survivors reported higher levels of spiritual coping than nonrural cancer survivors 
(p=0.04). All interview participants remarked how important their church support system was 
during their cancer journey, with their pastor coming to pray with them at the hospital and 




Nearly half (47%) of rural cancer survivors said it was somewhat or very hard to pay for 
transportation to treatment appointments, compared with only 19% of nonrural participants 
(p<0.0001). Additionally, 37% of rural cancer survivors reported that accessing transportation 
for treatment appointments was somewhat or very hard, compared with only 17% of nonrural 
participants (p<0.0019). Interview participants brought up the benefit of oncologists’ 
coordinating some of the treatments (e.g. chemotherapy) with community medical centers, as 
well as academic medical center satellite clinics with extending access to care to more rural areas 
and reducing the transportation burden. Participant 2 described being able to see his oncologist at 
a satellite clinic, “He comes up here from VCU a couple times a week so I go to him and think 
he’s a fantastic doctor, you know I trust him” as well as the reduction in travel time from an hour 
one-way to 10 minutes.  
 
While only 50% of rural cancer survivors regularly brought a list of questions to their treatment 
appointments, 70% brought a list of their medications. Rural cancer survivors reported more 
often bringing a list of medicines and requesting an explanation of a test or treatment than 
nonrural survivors (77% vs 65%, p=0.02; 83% vs 71%, p=0.01). Other behavioral skills 
measured did not significantly differ by geographic residence.  
 
Significant rural-nonrural differences were not detected for seeking health information, medical 
distrust, social support, and patient-provider communication. 
 
In multivariable logistic regression, three variables significantly predicted treatment 
nonadherence. First, the summary score variable of Transportation Barriers that indicates 
increasing barriers to transportation were significantly associated with treatment nonadherence 
(p=0.02; OR: 1.56, CI: 1.09-2.24). The interaction between geography and the behavior skill of 
bringing a list of questions to a clinic appointment was significant, with rural cancer survivors 
who do not bring a list of questions to appointments having over 3 times greater odds of being 
nonadherent (p=0.05; OR: 3.37, CI: 1.02-11.14). Patient interviews highlighted that the issue 
mainly stemmed from not knowing what to ask: “I didn’t have any trouble asking questions, I 
probably had trouble knowing what to ask. (Participant 3)” 
 
DISCUSSION 
The purpose of this study was to delineate social and behavioral determinants of rural cancer 
treatment nonadherence. We found that rural cancer survivors reported significant barriers to 
transportation access for cancer treatment appointments, and that transportation barriers were 
associated with treatment nonadherence. Half of rural participants reported sometimes or never 
bringing a list of questions to their treatment appointments. For these participants, nonadherence 
was 3 times the odds of nonadherence in nonrural participants. Mitigating transportation barriers 
and supporting appointment preparation could reduce cancer treatment nonadherence. The 
healthcare system is in a unique position to address these issues that could improve treatment 
adherence and cancer patient outcomes. 
Results from this study support what is found in the literature regarding rural disparities with 
regard to educational attainment, income, spiritual coping, and cancer fatalism.6,22,30 Rural cancer 
survivors were less likely to utilize online resources, including the internet as an information 
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source and accessing their online medical record. Greenberg and colleagues also found that rural 
residents are less likely to manage personal health information online or email a healthcare 
provider.38 In the present study, interview participants cited challenges with internet access, 
speed, and cost. A key contributor to this rural digital divide and critical to the deployment of 
digital health strategies is access to the mobile, internet or broadband infrastructure that supports 
these tools.  
A 2019 study found that residents of rural areas had reduced odds of having internet access 
compared with residents of nonrural areas (OR 0.75; 95% CI 0.67-0.84).77 Similarly, the Pew 
Research Center reported that 63% of rural residents say they have a broadband internet 
connection at home, compared with 75% of nonrural residents.79 The Federal Communications 
Commission’s 2019 Broadband Deployment Report found that over 26% of Americans in rural 
areas lack coverage from fixed terrestrial 25 Mbps/3 Mbps broadband that would allow for home 
internet access, as compared to only 1.7% of Americans in nonrural areas.36 Deployment of 
mobile Long-term Evolution, more commonly known as LTE  and the pathway to achieve high 
speed cellular internet service, still lags in rural areas. Specifically, only 70% of the rural 
population has service with a median speed of 10 Mbps/3 Mbps versus 93% of the nonrural 
population. An important step in addressing these disparities is to develop more granular 
broadband availability maps, a step taken by Congress in March 2020 in passing the Broadband 
Deployment Accuracy and Technological Availability Act.37  
Rural cancer survivors reported significant barriers to transportation for treatment appointments, 
specifically related to cost and access. Our study also demonstrated that transportation barriers 
are significantly associated with treatment nonadherence. Rural residents face longer median 
travel times to treatment centers, oncology specialists, and academic centers, yet higher volume 
centers are associated with improved patient outcomes.30,32 Median travel times reported in the 
literature range from 51 minutes to 97 minutes.33 Our study results are similar, with an average 
travel time of 85 minutes from rural participants' usual source of cancer care. Poverty creates 
substantial transportation barriers, making it a challenge for some rural residents to afford gas or 
a car. It has been estimated that over 1.6M rural households do not have cars, mostly 
concentrated in the South, Appalachia, and the Southwest.34 When specifically asked about 
transportation challenges for treatment appointments, nearly half of rural participants reported 
difficulty with paying for transportation, and 37% had difficulty. Our study documents that the 
substantial access barriers faced by rural populations do indeed influence treatment adherence. 
Our study identified that bringing a list of questions to clinic appointments was especially 
important in improving treatment adherence for rural cancer survivors. Various strategies to 
support appointment preparation have been implemented in the literature, including appointment 
preparation and Question Prompt Lists (QPLs). Roter pioneered in-person appointment 
preparation in the 1970s, and found that when patients were coached with a prompt sheet 
reviewing “possible questions in the areas of etiology, duration, severity, and prevention of 
illness,” they asked more questions and kept more appointments.165 While this area of research 
focuses on the interactive preparation prior to an appointment, a subset of studies highlight the 
use of QPLs. QPLs consist of a structured list of questions that patients can use as examples to 
gather information during clinic appointments, with the aim of information provision that is more 
personally relevant and sufficient to improve psychological and cognitive outcomes like anxiety 
and information recall.166 QPLs have been found to enhance question asking, decrease patient 
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anxiety at follow-up, improve information recall.166 Future rural cancer delivery research could 
utilize appointment preparation to support question development and treatment adherence. 
Regarding the theoretical model this study was based, two of the three IMB constructs 
significantly predicted nonadherence, Motivation and Behavioral Skills. When applied to 
medication adherence, the authors of the IMB model suggested that adherence information and 
motivation will be primarily expressed through adherence behavioral skills.49 The role of the 
IMB information construct has been inconsistent in the prediction of preventative behavior, and 
in the degree of independence between the information and motivation constructs.13 
Additionally, the relatively more modest correlation between information and the intended health 
behavior (compared to motivation and behavioral skills) is expected based on the IMB model’s 
assertion that information needs to be easily operationalized for it to result in behavior change, 
which is not always the case.9 While our measures of the CCM did not significantly predict 
adherence, aspects of the CCM can support behavioral skills and motivation, to ultimately 
improve adherence. 
Study strengths include the mixed methods approach utilized that combined survey data from 
validated scales with in-depth reflection from individual interviews. While the response rate 
from our study is modest compared with clinic based recruitment of cancer survivors, it is 
comparable to the response rate of mailed surveys. Follow-up with those who did not return a 
survey or opt-out was limited by pandemic restrictions. The response rate could have been higher 
had we been able to recruit participants in the clinic or follow-up with nonrespondents.  
Whereas the total participant sample was 26% Black, Black participants made up 24% of the 
study sample that consented to medical records access (p=0.04). Additionally, those who 
consented to medical records access skewed to higher levels of educational attainment and 
income (p<0.0001 and p=0.0004, respectively). Our results may not be fully representative of 
our target population because of this selection bias. However, the survey was able to recruit a 
high percentage of rural participants and approximately equal numbers of rural and nonrural 
respondents. The majority (78%) consented to medical records release, which did not differ by 
geographic location. The majority (77%) of rural survivors also consent to future contact, 
allowing us to contact them for recruitment into the interview portion of this study. We were able 
to allow the option of completing the survey online if the respondent preferred, which was 
selected by about 21% of participants. 
The factors identified in this study provide theory-based opportunities for interventions designed 
to improve treatment adherence among rural populations. Rural cancer survivors face significant 
barriers to transportation for treatment appointments and lack important skills for patient 
engagement. Mitigating transportation barriers and supporting appointment preparation could 
reduce cancer treatment nonadherence. The healthcare system is poised to address these issues 






Table 1. Sample population characteristics by medical records consent release  
 Total 
(N = 430) 
HIPAA 
Consent  
(N = 334) 
No HIPAA 
Consent 















Age 63.6 12.6 63.3 13.0 64.7 11.1 0.32 
Geography             0.99 
Rural 188 43.7 146 43.7 42 43.8   
Nonrural 242 56.3 188 56.3 54 56.3   
Gender       0.16 
    Male 159 37.9 130 39.6 29 31.5  
    Female 261 62.1 198 60.4 63 68.5  
Race/Ethnicity       0.04* 
    White 287 74.2 234 76.5 53 65.4  
    Black 100 25.8 72 23.5 28 34.6  
Education       <0.0001* 
Less than HS degree 48 11.5 27 8.3 21 23.3   
HS degree 74 17.8 51 15.6 23 25.6   
Some college/tech 
school 
114 27.3 92 28.1 22 24.4   
College degree 97 23.3 85 26.0 12 13.3   
Post college educ 84 20.1 72 22.0 12 13.3   
Income             0.0004* 
<$20,000 70 16.8 52 15.9 18 20.2   
$20,000 - <$50,000 76 18.2 61 18.6 15 16.9   
$50,000 - <$75,000 62 14.9 51 15.6 11 12.4   
$75,000 - <$100,000 53 12.7 47 14.3 6 6.7   
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>$100,000 70 16.8 63 19.2 7 7.9   
Unknown/Prefer not 
to say 
86 20.6 54 16.5 32 36.0   
Health Insurance             0.75 
Commercial 99 27.5 79 27.6 20 27.0   
Medicare 185 51.5 149 52.1 36 48.7   
Medicaid 45 12.5 33 11.5 12 16.2   





Table 2. Study population characteristics by geographic residence 
 Total 
(N = 334) 
Rural  
(N = 146) 
Nonrural 













Age 63.3 13.0 63.3 12.1 63.3 13.7 
0.99 
Distance to care 54.7 51.7 85.3 61.6 31.5 24.0 
<0.0001 
Nonadherence to chemo or 
radiation 
            
0.47 
0/1 appts 271 81.1 121 82.9 150 79.8 
  
2+ appts 
63 18.9 25 17.1 38 20.2 
  
Gender       
0.40 
    Male 130 39.6 53 37.0 77 41.6  
    Female 198 60.4 90 62.9 108 58.4  
Race/Ethnicity       
0.68 
    White 234 76.5 104 75.4 130 77.4  
    Black 72 23.5 34 24.6 38 22.6  
Education       0.005* 
Less than HS degree 27 8.3 14 9.9 13 7.0   
HS degree 51 15.6 27 19.0 24 13.0   
Some college/tech school 92 28.1 47 33.1 45 24.3   
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College degree 85 26.0 36 25.4 49 26.5   
Post college educ 72 22.0 18 12.7 54 29.2   
Income             0.0027* 
<$20,000 52 15.9 31 21.8 21 11.3   
$20,000 - <$50,000 61 18.6 30 21.1 31 16.7   
$50,000 - <$75,000 51 15.6 22 15.5 29 15.6   
$75,000 - <$100,000 47 14.3 17 12.0 30 16.1   
>$100,000 63 19.2 15 10.6 48 25.8   
Unknown/Prefer not to say 54 16.5 27 19.0 27 14.5   
Insurance             0.028* 
Commercial 79 27.6 22 18.8 57 33.7   
Medicare 149 52.1 65 55.6 84 49.7   
Medicaid 33 11.5 18 15.4 15 8.9   
Other 25 8.7 12 10.3 13 7.7   
Clinical stage             0.87 
1 35  32.1 15 36.6 20 29.4   
2 36 33.0 12 29.3 24 35.3   
3 17 15.6 6 14.6 11 16.2   
4 21 19.3 8 19.5 13 19.1   
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Access to transportation for 
treatment appointmentsi 
            <0.0001* 
Very/somewhat easy 245 74.5 90 63.4 155 82.9   
Somewhat/Very hard 84 25.5 52 36.6 32 17.1   
Able to or could afford time off 
work for treatment 
appointmentsi 
            0.0019* 
Very/Somewhat easy 230 76.4 82 67.2 148 82.7   
Somewhat/Very hard 71 23.6 40 32.8 31 17.3   
Able to pay for transportation to 
treatment appointmentsi 
            <0.0001* 
Very/Somewhat easy 217 69.3 70 53.4 147 80.8   
Somewhat/Very hard 96 30.7 61 46.6 35 19.2   
 iThe three transportation access questions comprise the Transportation Barriers scale included in 






Table 3. IMB-CCM constructs  
 Total 
(N = 334) 
Rural  
(N = 146) 
Nonrural 














Information        
Seek health info             0.60 
No 53 16.3 25 17.2 28 14.9   
Yes 278 83.7 118 80.8 160 85.1   
Seek health info online             0.001* 
No 179 53.6 93 63.7 86 45.7   
                                    Yes 155 46.4 53 36.3 102 54.3   
Electronic Info Accessibility 
Score 
2.8 0.77 2.6 0.79 3.0 0.74 0.0008* 
Motivation        
Medical Distrust             0.21 
Not at all/A little 3 0.9 2 1.4 1 0.5   
Some/A lot 321 99.1 139 98.6 182 99.5   
Belief that cancer prevention 
isn’t possible 
            0.01* 
Strongly/somewhat agree 89 27.4 49 34.3 40 22.0   
Somewhat/Strongly disagree 236 72.6 94 65.7 142 78.0  
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Spiritual Coping Score 2.7 1.1 2.8 1.1 2.6 1.1 0.04* 
Transportation Barriers Score 1.8 0.84 2.1 0.88 1.6 0.76 <0.0001* 
Behavioral Skills        
Bring a list of questions to 
medical appointments 
      0.1 
Always/usually 182 55.0 72 50.0 110 58.8  
Sometimes/never 149 45.0 72 50.0 77 41.2  
Bring a list of medicines to 
medical appointments 
      0.02* 
Always/usually 233 70.2 112 76.7 121 65.1  
Sometimes/never 99 29.8 34 23.3 65 35.0  
Bring health information to a 
medical appointment 
      0.85 
Always/usually 70 21.0 30 20.6 40 21.4  
Sometimes/never 263 79.0 116 79.5 147 78.6  
Request an explanation of a test 
or treatment 
      0.01* 
Always/usually 255 76.4 121 82.9 134 71.3  
Sometimes/never 79 23.7 25 17.1 54 28.7  
Read information about a new 
prescription 
      0.31 
Always/usually 246 74.3 111 77.1 135 72.2  
Sometimes/never 85 25.7 33 22.9 52 27.8  
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Do your own research on a 
health or medical topic 
      0.58 
Always/usually 169 51.1 76 52.8 93 49.7  
Sometimes/never 162 48.9 68 47.2 94 50.3  
Community        
Social Support Score 4.3 0.9 4.3 0.9 4.3 0.9 0.59 
Health Systems        
Access online medical record             0.01* 
No 105 31.6 57 39.0 48 25.8   
Yes 227 68.4 89 61.0 138 74.2   
Use app to communicate with a 
healthcare provider 
      0.17 
Yes 79 28.4 29 24.2 50 31.7  
No 199 71.6 91 75.8 108 68.4  
Patient-Provider 
Communication 






Table 4. Multivariable model of treatment nonadherence 
 Estimate SE 
Chi 
Square 
P-value OR 95% CI 
Intercept -2.56 0.42 36.80 <.0001 --   
Transportation Barriers score 0.44 0.18 5.83 0.02 1.56* 1.09-2.24 
Geography (ref = Nonrural) -0.37 0.19 3.95 0.05 --   
Bring a list of questions to 
doctor’s appt  
(Ref = Always/Usually) 
0.26 0.18 2.07 0.15 --   
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CHAPTER 5: Discussion 
 
Nonadherence to cancer treatment is associated with poorer patient outcomes, yet represents a 
modifiable target for health behavior interventions.9–16 The purpose of the dissertation research 
was to elucidate social and behavioral factors related to oncology treatment nonadherence to 
inform the development of targeted, tailored approaches to improve rural oncology outcomes. 
These goals were accomplished by a rigorous mixed methods approach utilizing a systematic 
review of available literature, cancer registry and hospital billing claims data, population-based 
surveys, and semi-structured interviews.  
Digital health strategies have the potential to mitigate rural cancer disparities. Despite progress 
made in understanding how digital health can enhance cancer care, previous reviews have not 
focused on their use in rural populations. Paper 1 systematically and critically examined existing 
literature to understand how digital technologies have been used to support rural oncology care. 
We identified 53 studies that addressed the use of technology in rural cancer care delivery, a 
comparatively small number, representing a significant gap in the literature. Across all studies 
was the consensus that rural cancer survivors value digital technology approaches to their care, 
with results varying by type of technology. Ease of use and technological requirements are 
important considerations in rural populations. 
Critical to reducing the rural digital divide and the deployment of digital health strategies is 
increasing mobile, internet or broadband service in rural areas. While steps are being taken to 
address this geographic disparity, the fact remains that nearly 30% of Americans live in areas 
that lack the coverage needed for home internet. The findings of this review suggest further 
implementation and expansion of telemedicine and phone-based strategies in rural cancer care 
delivery. There are significant gaps in the literature regarding patient portals, mobile apps, 
interactive voice response, social media, and text messaging that should be investigated. 
Opportunities exist for innovative digital health technologies to address rural cancer control. 
The goal of Paper 2 was to determine sociodemographic and clinical factors associated with 
radiation treatment nonadherence among rural and nonrural cancer patients. We utilized cancer 
registry and hospital billing claims data to define radiation treatment nonadherence and potential 
covariates and confounders. We found that uninsured rural cancer patients with more 
appointments were more likely to be nonadherent, with the odds of nonadherence increasing by 
14% with each additional appointment date (OR 1.14, 95% CI 1.09-1.20). Patients with clinical 
stage 4 cancer also had an increased odds of being nonadherent. This analysis revealed 
actionable clinical implications. Rural patients with more total treatment appointments and those 
with more advanced disease were more likely to be nonadherent. In recognition of this finding, 
the healthcare team can focus on risk stratification; identifying key access barriers for each 
patient or adopting additional assessments of barriers to care for this patient population; offering 
additional support resources; and scheduling a check in halfway through the treatment plan to 
support treatment adherence. The evidence-based practice of shorter radiation treatment 
regimens should continue to be considered. While we were able to identify key contributors to 
radiation treatment nonadherence, we were limited to cancer registry and hospital billing claims 
data. Paper 3 built upon these results. 
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Paper 3 found that rural cancer survivors reported significant barriers to transportation access for 
cancer treatment appointments, and that transportation barriers were associated with treatment 
nonadherence. Half of rural participants reported sometimes or never bringing a list of questions 
to their treatment appointments. For these participants, nonadherence was 3 times the odds of 
nonadherence in nonrural participants. Mitigating transportation barriers and supporting 
appointment preparation could reduce cancer treatment nonadherence. The healthcare system is 
in a unique position to address these issues that could improve treatment adherence and cancer 
patient outcomes. Survey results from Paper 3 also found that 94% of participants reported 
having a cell phone. Most participants also reported having a smartphone, though 21% of rural 
survivors did not (vs 9% nonrural, p=0.002). A higher percentage of rural participants reported 




Treatment nonadherence rates in the dissertation studies ranged from 19 to 25%. While the 
overall nonadherence rate was not significantly different by geographic location, rural adherence 
rates were higher with increasing length of treatment regimen. We identified several key social 
and behavioral factors that served as barriers and facilitators to treatment adherence among rural 
cancer survivors. 
 
Transportation access was a significant issue faced by rural cancer survivors, both in terms of 
cost and physical access. While the healthcare system can serve to mitigate transportation 
barriers, religious communities are also a significant source of support. Patients readily reported 
relying on members of their church to meet transportation needs, defining faith as a cohesive 
factor that connected people across families, social circles, and sociodemographics. Across all 
studies was the consensus that rural cancer survivors value digital technology approaches to their 
care, yet technology type can create a barrier. Ease of use and technological requirements are 
important considerations in rural populations. Rural cancer survivors were also very amenable to 
research, including those involving digital health interventions and treatment clinical trials. Half 
of rural participants reported sometimes or never bringing a list of questions to their treatment 
appointments, yet those who did had improved treatment adherence. Conversely, rural cancer 
survivors were engaged in their appointments and readily requested explanations of tests or 
treatments. These findings support future research emphasis on question generating and 
supporting question recall versus coaching to reduce cultural barriers to question asking. 
 
I also identified several ways that health systems can play a key role in reducing treatment 
nonadherence. First, shorter radiation treatment regimens have been established as evidence-
based practice, and hypofractionated treatment options should continue to be offered and 
encouraged. Secondly, the healthcare team can focus on identifying key access barriers for each 
patient or adopting additional assessments of barriers to care for this patient population; offering 
additional support resources; and scheduling a check in halfway through the treatment plan to 
support treatment adherence. Risk stratification can be utilized when implementing interventions 
to improve treatment adherence. 
 
Critical to reducing the rural digital divide and the deployment of digital health strategies is 
increasing mobile, internet or broadband service in rural areas. While steps are being taken to 
38 
 
address this geographic disparity, the fact remains that nearly 30% of Americans live in areas 
that lack the coverage needed for home internet. Findings from this dissertation research suggest 
further implementation and expansion of telemedicine and phone-based strategies in rural cancer 
care delivery. There are significant gaps in the literature regarding patient portals, mobile apps, 
interactive voice response, and text messaging that should be investigated, with text messaging 
being the most pragmatic in the rural patient population. Of note, 94% of the survey participants 
reported having a cell phone, while significantly fewer rural survivors had a smartphone, 79% vs 
91%. Opportunities exist for innovative digital health technologies that healthcare systems are 
well-positioned to implement and address rural cancer control. 
 
Finally, we identified gaps in the literature and study design recommendations. Overall, the 
literature includes very few randomized trials and samples sizes are low. Most studies examining 
the use of digital health technology that involve rural populations restrict participants to those 
with internet access yet do not report the number of potential participants that were excluded due 
to access. Few studies measured access to care variables. While this phase of research did not 
include a randomized trial, we did attempt to address literature gaps by having large study 
samples, not restricted by internet access, and including access measures in the survey. Despite 
the availability of standardized reporting guidelines by study design like CONSORT and 
STROBE, there is room for improvement in practice in terms of both study design and reporting 
results. Investigators should take advantage of available guidelines to improve the quality of 
literature in this research area.  
 
In summary, multilevel factors contribute to the observed geographic differences in cancer 
treatment adherence and outcomes, including sociodemographic inequities, reduced self-
management skills, and diminished access to healthcare, psychosocial services, and technology. 
Self-management skills, including appointment preparation, that engage patients as active and 
effective managers of their health result in more positive patient outcomes, including treatment 
adherence; yet these skills are not routinely performed by patients or incorporated as part of 
oncology care. Digital health strategies can support patient self-management, which may serve to 
mitigate rural health disparities, and these dissertation studies supported the acceptability of 
technology-based research in rural cancer populations. Barriers to technology access among rural 
residents remain, however, and need to be considered in study design. Innovative strategies to 
integrate self-management support within oncology care may be a promising way to reduce rural 
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Paper 1 Appendix 1. Systematic Literature Review Search 
Pubmed search 
Search set #1: ( "Rural Population"[Mesh] OR "Rural Health Services"[Mesh] OR "Rural 
Health"[Mesh] OR  "Hospitals, Rural"[Mesh]  OR “rural” [TIAB]) 
Search set #2: ("Mobile Health Units"[Mesh] OR "Mobile Applications"[Mesh] OR 
"Telemedicine"[Mesh] OR "Text Messaging"[Mesh] OR "Internet"[Mesh] OR "Patient 
Portals"[Mesh] OR "Technology/diagnosis"[Mesh:NoExp] OR "Technology/diagnostic 
imaging"[Mesh:NoExp] OR "Technology/instrumentation"[Mesh:NoExp] OR 
"Technology/therapeutic use"[Mesh:NoExp] OR "Medical Informatics"[Mesh] OR “health 
information technology”[TIAB] OR “health IT”[TIAB] OR “patient portal*”[TIAB] OR “patient 
internet portal*”[TIAB] OR “decision support*”[TIAB] OR “clinical reminder*”[TIAB] OR 
“electronic reminder*”[TIAB] OR “reminder system*”[TIAB] OR “computer assisted decision 
making”[TIAB] OR “computer assisted detection”[TIAB] OR “computer assisted 
diagnosis”[TIAB] OR “computer assisted treatment”[TIAB] OR “computer assisted 
therapy”[TIAB] OR “decision support”[TIAB] OR “decision aid”[TIAB]) OR “app”[TIAB] or 
“text message”[TIAB] or “mobile”[TIAB] or “digital”[TIAB] or “mhealth”[TIAB] or 
“ehealth”[TIAB] or “phone”[TIAB] or “social media”[TIAB] 
Search set #3: (“cancer”[TIAB] OR “neoplasms”[MeSH] OR “tumor”[TIAB] OR 
“tumour”[TIAB] OR “oncolog*”[TIAB]) 
Limitations: Last 10 years and articles in English 
Pubmed Total: 341 
 CINAHL Complete search 
Search set #1: (MH "Rural Health Centers") OR (MH "Rural Health Personnel") OR (MH 
"Hospitals, Rural") OR (MH "Rural Population") OR (MH "Rural Health Services") OR (MH 
"Rural Health Nursing") OR (MH "Rural Areas") OR (MH "Rural Health") OR "rural" 
51 
 
Search set #2: (MH "Mobile Health Units") OR (MH "Telehealth") OR "mobile health unit" OR 
(MH "Mobile Applications") OR "mobile applications" OR (MH "World Wide Web 
Applications") OR (MH "Telemedicine") OR "telemedicine" OR (MH "Telerehabilitation") OR 
(MH "Telepsychiatry") OR (MH "Text Messaging") OR "text messaging" OR (MH "Internet") 
OR "internet" OR "patient portal" OR (MH "Technology/ES/ED/EV") OR "technology" OR 
(MH "Medical Informatics") OR "medical informatics" OR (MH "Information Technology") OR 
"health information technology" OR (MH "Decision Support Systems, Clinical") OR "decision 
support" OR "clinical reminder" OR (MH "Reminder Systems") OR (MH "Decision Making, 
Computer Assisted") OR (MH "Diagnosis, Computer Assisted") 
Search set #3: (MH "Neoplasms+") OR "cancer" OR (MH "Cancer Patients") OR (MH "Cancer 
Screening") OR (MH "Cancer Survivors") OR (MH "Early Detection of Cancer") OR (MH 
"Oncology") OR "oncology" OR "tumor" 
Limitations: Last 10 years, articles in English, exclude MEDLINE articles 
CINAHL Complete: 54 
PsychINFO search 
Index Terms: {Rural Environments} AND Index Terms: {Neoplasms} AND Index Terms: 
{Telemedicine} OR {Internet} OR {Computer Mediated Communication} OR {Computer 
Assisted Therapy} OR {Computer Assisted Diagnosis} OR {Mobile Devices} OR {Computers} 
OR {Electronic Communication} OR {Technology} OR {Text Messaging} OR {Cellular 
Phones} OR {Text Messaging} OR {Mobile Devices} OR {Internet} OR {Telemedicine} OR 
{Social Media} OR {Online Therapy} OR {Online Experiments} OR {Websites} OR 
{Information Technology} OR {Decision Support Systems} OR {Artificial Intelligence} OR 
{Computer Applications} AND Peer-Reviewed Journals only AND Year: 2008 To 9999 
PyschINFO: 4 (all duplicates) 
 Embase search 
Search set #1: rural health/ or rural area/ or rural health nursing/ or rural.mp. or rural health care/ 
or rural population/       
Search set #2: mobile application/ or technology/ or telemedicine/ or mobile phone/ or mobile 
health.mp. Or telemedicine.mp. or telemedicine/ or telecommunication/ or text messaging.mp. or 
text messaging/ or decision support system/ or computer assisted diagnosis/ or internet.mp. or 
Internet/ or patient portal.mp. or information technology/ or information technology device/ or 
health information technology.mp. or medical informatics/ or computer assisted diagnosis/ or 
computer assisted.mp. or reminder system/ or reminder.mp. 
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Search set #3: cancer.mp. or malignant neoplasm/ or tumor.mp. or neoplasm/ or surgical 
oncology/ or oncology/ or oncology.mp. or oncology nursing/ or radiation oncology/ 
Limitations: Last 10 years and Embase journal articles in English     
Embase: 204 
  
Articles from Pubmed, CINAHL Complete, PsychINFO and Embase = 595 
Articles from reference lists = 5 
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Paper 3 Appendix 1. Summary of participant recruitment 
 Rural %   Nonrural %   Total 
Surveys 1050     1050     2027 
 Same household or bad address 89     13     102 
  Total mailed 961 48%   1037 52%   1998 
Total participants 188 44%   242 56%   430 
Completed by mail 153 81%   186 77%   242 
Completed online 35 19%   56 23%   188 
Consent to Registry 154 82%   204 85%   358 
Consent to Future Contact 144 77%   194 80%   338 
Consent to Medical Records 146 78%   188 78%   334 
Eligible, Non-response  
(reason: refusal) 30 51%   29 49%   59 
Unknown eligibility, No Returned 
Questionnaire 744 49%   768 50%   1512 
Response Ratei  20%   23%   
Refusal Ratei  3%   3%   
I Calculated based on Response Rate 1 and Refusal Rate 1 of the American Association for 





Paper 3 Appendix 2. Semistructured Interview Guide 
Thank you so much for your time and willingness to participate. As a brief introduction, 
the goal of this conversation is to better understand the challenges you may have faced and 
the resources you have had during your cancer journey as a rural resident. The documents 
that we just went over explain the purpose of the study, the steps we are taking to protect 
your privacy, and give us permission to audiorecord the conversation for research 
purposes. We audiorecord so that we can make sure we capture everything that is 
discussed, since learning about your experiences is important to us and I can’t take notes as 
fast as I would like! The conversation will take about 1 hour, and you will receive $20 as a 
thank you for your time. Do you have any questions before we begin? 
I.      Rurality 
Thank you again for your time. Since this study is interested in learning about rural residents’ 
experiences with cancer, I’d like to first start out with learning a little about the area in which 
you live. Could you please describe your community? 
Prompts: town name, how long they’ve lived there, main areas/businesses, what the town 
is known for 
 When you hear people talking about rural areas, what do you think defines rural? What does 
‘rural’ mean to you? 
 II.     Cancer experience 
We know that no two cancer survivors’ situations and experiences are the same. Your experience 
and reactions may be quite different from another survivor at the same stage or with a similar 
diagnosis. As a rural resident, it could also be quite different from someone living in a city. 
Please tell us a little bit about your cancer journey. 
Prompts: When were you diagnosed, what treatment did you receive, what is the status of 
your cancer now 
Social Support 
Can you tell me about who has been most involved in your cancer care? 
Prompts: who are your sources of support? Family, friends, church, support groups, 
online forums? How important is faith or religion to you? Can you tell me about how it 
has influenced your cancer journey? 
Healthcare access 
Can you tell me about where you received cancer care for your first type of treatment? 





How did cancer treatment affect your finances? 
How did cancer treatment impact your work? 
Treatment adherence and engagement 
Can you please tell me about what you had to do for treatment? 
Prompts: How often did you have to go to the doctor for cancer treatment? 
Can you please tell me what you had to do for each appointment? 
Prompts: How many appointments do you think would be ok to miss? Did you ever miss 
an appointment? What might help you to not miss an appointment? What made it harder 
to attend an appointment? How would you feel if you missed an appointment? Would 
you do anything to prepare for it? What would you normally bring with you? Would you 
ever prepare a list of questions beforehand? Take notes during? 
Healthcare team: medical distrust, shared decision-making, support services 
Can you tell me about your cancer care team? 
Prompts: Who is part of your cancer care team? Who did you talk with the most? Have 
you ever worked with a social worker or a nurse navigator? Someone with palliative 
care? 
Tell me about how you interact with your cancer care team. 
Prompts: How comfortable are you with the medical team? Do they seem trustworthy? 
How do you feel about the way the medical team talks with you? How they explain your 
treatment? When you have needed to make decisions about your cancer care, who 
normally makes them? 
Non-standard of care 
How important do you feel medical care is in treating cancer? 
Prompts: Have you heard of clinical trials? How do you feel about them? How do you 
feel about alternative therapies? 
Information 
Where do you usually go for information about your cancer and treatment? 
Prompts: e.g. Doctors, more experienced survivors, online? What sources of information 
do you find most useful? Why? 
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Can you tell me about how your cancer care team described your cancer and treatment plan? 
Prompts: How well do you think your cancer care team described your cancer and cancer 
care plan? How do you feel about asking your cancer care team questions? 
How do you usually access the internet? How often do you use it? 
Prompts: Do you have a smartphone? How would you feel about getting text messages 
related to your cancer care? How do you feel about using an online portal to message 
your cancer care team? To look at your medical information? 
III. Closing 
We know that it's not always easy for people to share their experiences as cancer survivors, and 
we're very grateful to you for talking with us. We’ve come to the end of our questions. Do you 
have any questions for me? 
Thank you for your time. 
  
 
